Notices. Notice of Final Results of Antidumping Duty Administrative Review

27,464 words·~125 min read·/register/2006/12/13/06-9666

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 3410-11-M DEPARTMENT OF COMMERCE International Trade Administration A-821-819 Notice of Extension of Time Limit for Preliminary Results of Antidumping Duty Administrative Review: Magnesium Metal From the Russian Federation AGENCY: Import Administration, International Trade Administration, Department of Commerce EFFECTIVE DATE: December 13, 2006. FOR FURTHER INFORMATION CONTACT: Gene Calvert or Jun Jack Zhao,AD/CVD Operations, Office 6, Import Administration, International Trade Administration, U.S. Department of Commerce, 14th Street and Constitution Avenue, NW, Washington, DC 20230; telephone:

(202)482-3586 or

(202)482-1396, respectively. Background The Department of Commerce (the Department) published an antidumping duty order on magnesium metal from the Russian Federation on April 15, 2005. *See Notice of Antidumping Duty Order: Magnesium Metal from the Russian Federation* , 70 FR 19930 (April 15, 2005). On April 4, 2006 and April 6, 2006, PSC VSMPO-AVISMA Corporation (formerly known as JSC AVISMA Titianium-Magnesium Works) and its affiliated U.S. reseller VSMPO-Tirus, U.S. Inc., and Solikamsk Magnesium Works, Russian Federation producers of the subject merchandise, respectively requested that the Department conduct an administrative review. On April 28, 2006, U.S. Magnesium Corporation LLC, petitioner in the investigation, also requested that the Department conduct an administrative review. On May 31, 2006, the Department published a notice of initiation of an administrative review of the antidumping duty order on the subject merchandise, for the period October 4, 2004, through March 31, 2006. *See Initiation of Antidumping and Countervailing Duty Administrative Reviews and Request for Revocation in Part* , 71 FR 30864 (May 31, 2006). The preliminary results of this administrative review are currently due no later than December 31, 2006. Extension of Time Limit for Preliminary Results Pursuant to section 751(a)(3)(A) of the Tariff Act of 1930, as amended, (the Act), the Department shall issue preliminary results in an administrative review of an antidumping duty order within 245 days after the last day of the anniversary month of the date of the publication of the order. The Act further provides, however, that the Department may extend the deadline for the completion of the preliminary results of a review from 245 days to 365 days if it determines that it is not practicable to complete the preliminary results within the 245-day period. *See* section 751(a)(3)(A) of the Act. Due to the complexity of issues present in this administrative review, such as complicated cost accounting issues regarding the revaluation of capital assets and the calculation of the proper byproduct offset values which will be used to determine production costs of the subject merchandise, the Department has determined that it is not practicable to complete the review within the original time period. Section 751(a)(3)(A) of the Act and section 351.213(h)(2) of the Department's regulations allow the Department to extend the deadline for the preliminary results to a maximum 365 days from the last day of the anniversary month of the order. For the reason noted above, we are extending the time for the completion of preliminary results until no later than April 30, 2007. The deadline for the final results of this administrative review continues to be 120 days after the publication of the preliminary results. This notice is issued and published in accordance with section 751(a)(3)(A) of the Act. Dated: December 6, 2006. Stephen J. Claeys Deputy Assistant Secretary for Import Administration [FR Doc. E6-21209 Filed 12-12-06; 8:45 am] BILLING CODE 3510-DS-S DEPARTMENT OF COMMERCE International Trade Administration [A-428-825] Stainless Steel Sheet and Strip in Coils From Germany; Notice of Final Results of Antidumping Duty Administrative Review AGENCY: Import Administration, International Trade Administration, Department of Commerce. ACTION: Notice of Final Results of Antidumping Duty Administrative Review. SUMMARY: On August 8, 2006, the Department of Commerce (the Department) published the preliminary results of administrative review of the antidumping duty order covering stainless steel sheet and strip in coils from Germany. *See Stainless Steel Sheet and Strip in Coils from Germany; Notice of Preliminary Results of Antidumping Duty Administrative Review* , 71 FR 45024 (August 8, 2006) ( *Preliminary Results* ). The merchandise covered by this order is stainless steel sheet and strip in coils as described in the “Scope of the Order” section of this notice. The period of review

(POR)is July 1, 2004, through June 30, 2005. In the *Preliminary Results* we invited parties to provide comments. Based on our analysis of the comments received, we have made changes to the margin calculation. Therefore, the final results differ from the preliminary results. The final weighted-average dumping margin for the reviewed firm is listed below in the section entitled “Final Results of the Review.” EFFECTIVE DATE: December 13, 2006. FOR FURTHER INFORMATION CONTACT: Deborah Scott, Tyler Weinhold, or Robert James, AD/CVD Operations, Office 7, Import Administration, International Trade Administration, U.S. Department of Commerce, 14th Street and Constitution Avenue, NW, Washington, DC 20230; telephone:

(202)482-2657,

(202)482-1121, and

(202)482-0649, respectively. SUPPLEMENTARY INFORMATION: Background On August 8, 2006, the Department published the preliminary results of administrative review of the antidumping order covering stainless steel sheet and strip in coils from Germany. *See Preliminary Results* . In the *Preliminary Results* we invited parties to provide comments. In response, the Department received a case brief from German producers ThyssenKrupp Nirosta GmbH (ThyssenKrupp Nirosta), ThysssenKrupp Nirosta Prazisionsband GmbH (TKNP), ThyssenKrupp VDM GmbH (TKVDM), along with their affiliated U.S. importers ThyssenKrupp Nirosta North America, Inc. (TKNNA) and ThyssenKrupp VDM USA, Inc. (TKVDMUSA) (collectively, TKN) on September 7, 2006. Allegheny Ludlum, North American Stainless, United Auto Workers Local 3303, United Steelworkers of America, AFL-CIO/CLC, and Zanesville Armco Independent Organization (collectively, Petitioners) submitted a rebuttal brief on September 14, 2006. No party requested a hearing; accordingly, none was held. Scope of the Order The products covered by this order are certain stainless steel sheet and strip in coils. Stainless steel is an alloy steel containing, by weight, 1.2 percent or less of carbon and 10.5 percent or more of chromium, with or without other elements. The subject sheet and strip is a flat-rolled product in coils that is greater than 9.5 mm in width and less than 4.75 mm in thickness, and that is annealed or otherwise heat treated and pickled or otherwise descaled. The subject sheet and strip may also be further processed ( *e.g.* , cold-rolled, polished, aluminized, coated, *etc.* ) provided that it maintains the specific dimensions of sheet and strip following such processing. The merchandise subject to this order is currently classifiable in the Harmonized Tariff Schedule of the United States (HTSUS) at subheadings: 7219.13.0031, 7219.13.0051, 7219.13.0071, 7219.1300.81 1 , 7219.14.0030, 7219.14.0065, 7219.14.0090, 7219.32.0005, 7219.32.0020, 7219.32.0025, 7219.32.0035, 7219.32.0036, 7219.32.0038, 7219.32.0042, 7219.32.0044, 7219.33.0005, 7219.33.0020, 7219.33.0025, 7219.33.0035, 7219.33.0036, 7219.33.0038, 7219.33.0042, 7219.33.0044, 7219.34.0005, 7219.34.0020, 7219.34.0025, 7219.34.0030, 7219.34.0035, 7219.35.0005, 7219.35.0015, 7219.35.0030, 7219.35.0035, 7219.90.0010, 7219.90.0020, 7219.90.0025, 7219.90.0060, 7219.90.0080, 7220.12.1000, 7220.12.5000, 7220.20.1010, 7220.20.1015, 7220.20.1060, 7220.20.1080, 7220.20.6005, 7220.20.6010, 7220.20.6015, 7220.20.6060, 7220.20.6080, 7220.20.7005, 7220.20.7010, 7220.20.7015, 7220.20.7060, 7220.20.7080, 7220.20.8000, 7220.20.9030, 7220.20.9060, 7220.90.0010, 7220.90.0015, 7220.90.0060, and 7220.90.0080. Although the HTSUS subheadings are provided for convenience and customs purposes, the Department's written description of the merchandise under this order is dispositive. 1 Due to changes to the HTS numbers in 2001, 7219.13.0030, 7219.13.0050, 7219.13.0070, and 7219.13.0080 are now 7219.13.0031, 7219.13.0051, 7219.13.0071, and 7219.13.0081, respectively. Excluded from the scope of the order are the following:

(1)sheet and strip that is not annealed or otherwise heat treated and pickled or otherwise descaled,

(2)sheet and strip that is cut to length,

(3)plate ( *i.e.* , flat-rolled stainless steel products of a thickness of 4.75 mm or more),

(4)flat wire ( *i.e.* , cold-rolled sections, with a prepared edge, rectangular in shape, of a width of not more than 9.5 mm), and

(5)razor blade steel. Razor blade steel is a flat-rolled product of stainless steel, not further worked than cold-rolled (cold- reduced), in coils, of a width of not more than 23 mm and a thickness of 0.266 mm or less, containing, by weight, 12.5 to 14.5 percent chromium, and certified at the time of entry to be used in the manufacture of razor blades. *See* chapter 72 of the HTSUS, “Additional U.S. Note” 1(d). Flapper valve steel is also excluded from the scope of the order. This product is defined as stainless steel strip in coils containing, by weight, between 0.37 and 0.43 percent carbon, between 1.15 and 1.35 percent molybdenum, and between 0.20 and 0.80 percent manganese. This steel also contains, by weight, phosphorus of 0.025 percent or less, silicon of between 0.20 and 0.50 percent, and sulfur of 0.020 percent or less. The product is manufactured by means of vacuum arc remelting, with inclusion controls for sulphide of no more than 0.04 percent and for oxide of no more than 0.05 percent. Flapper valve steel has a tensile strength of between 210 and 300 ksi, yield strength of between 170 and 270 ksi, plus or minus 8 ksi, and a hardness

(Hv)of between 460 and 590. Flapper valve steel is most commonly used to produce specialty flapper valves in compressors. Also excluded is a product referred to as suspension foil, a specialty steel product used in the manufacture of suspension assemblies for computer disk drives. Suspension foil is described as 302/304 grade or 202 grade stainless steel of a thickness between 14 and 127 microns, with a thickness tolerance of plus-or-minus 2.01 microns, and surface glossiness of 200 to 700 percent Gs. Suspension foil must be supplied in coil widths of not more than 407 mm, and with a mass of 225 kg or less. Roll marks may only be visible on one side, with no scratches of measurable depth. The material must exhibit residual stresses of 2 mm maximum deflection, and flatness of 1.6 mm over 685 mm length. Certain stainless steel foil for automotive catalytic converters is also excluded from the scope of this order. This stainless steel strip in coils is a specialty foil with a thickness of between 20 and 110 microns used to produce a metallic substrate with a honeycomb structure for use in automotive catalytic converters. The steel contains, by weight, carbon of no more than 0.030 percent, silicon of no more than 1.0 percent, manganese of no more than 1.0 percent, chromium of between 19 and 22 percent, aluminum of no less than 5.0 percent, phosphorus of no more than 0.045 percent, sulfur of no more than 0.03 percent, lanthanum of less than 0.002 or greater than 0.05 percent, and total rare earth elements of more than 0.06 percent, with the balance iron. Permanent magnet iron-chromium-cobalt alloy stainless strip is also excluded from the scope of this order. This ductile stainless steel strip contains, by weight, 26 to 30 percent chromium, and 7 to 10 percent cobalt, with the remainder of iron, in widths 228.6 mm or less, and a thickness between 0.127 and 1.270 mm. It exhibits magnetic remanence between 9,000 and 12,000 gauss, and a coercivity of between 50 and 300 oersteds. This product is most commonly used in electronic sensors and is currently available under proprietary trade names such as “Arnokrome III.” 2 2 “Arnokrome III” is a trademark of the Arnold Engineering Company. Also excluded from this order is a permanent magnet iron-chromium-cobalt stainless steel strip containing, by weight, 13 percent chromium, 6 percent cobalt, 71 percent iron, 6 percent nickel and 4 percent molybdenum. The product is supplied in widths up to 1.27 cm (12.7 mm), inclusive, with a thickness between 45 and 75 microns, inclusive. This product exhibits magnetic remanence between 400 and 780 nWb, and coercivity of between 60 and 100 oersteds. This product is currently supplied under the trade name “SemiVac 90.” Certain electrical resistance alloy steel is also excluded from the scope of this order. This product is defined as a non-magnetic stainless steel manufactured to American Society of Testing and Materials

(ASTM)specification B344 and containing, by weight, 36 percent nickel, 18 percent chromium, and 46 percent iron, and is most notable for its resistance to high temperature corrosion. It has a melting point of 1390 degrees Celsius and displays a creep rupture limit of 4 kilograms per square millimeter at 1000 degrees Celsius. This steel is most commonly used in the production of heating ribbons for circuit breakers and industrial furnaces, and in rheostats for railway locomotives. The product is currently available under proprietary trade names such as “Gilphy 36.” 3 3 “Gilphy 36” is a trademark of Imphy, S.A. Certain martensitic precipitation-hardenable stainless steel is also excluded from the scope of this order. This high-strength, ductile stainless steel product is designated under the Unified Numbering System

(UNS)as S45500-grade steel, and contains, by weight, 11 to 13 percent chromium, and 7 to 10 percent nickel. Carbon, manganese, silicon and molybdenum each comprise, by weight, 0.05 percent or less, with phosphorus and sulfur each comprising, by weight, 0.03 percent or less. This steel has copper, niobium, and titanium added to achieve aging, and will exhibit yield strengths as high as 1700 Mpa and ultimate tensile strengths as high as 1750 Mpa after aging, with elongation percentages of 3 percent or less in 50 mm. It is generally provided in thicknesses between 0.635 and 0.787 mm, and in widths of 25.4 mm. This product is most commonly used in the manufacture of television tubes and is currently available under proprietary trade names such as “Durphynox 17.” 4 4 “Durphynox 17” is a trademark of Imphy, S.A. Finally, three specialty stainless steels typically used in certain industrial blades and surgical and medical instruments are also excluded from the scope of this order. These include stainless steel strip in coils used in the production of textile cutting tools ( *e.g.* , carpet knives). 5 This steel is similar to AISI grade 420 but containing, by weight, 0.5 to 0.7 percent of molybdenum. The steel also contains, by weight, carbon of between 1.0 and 1.1 percent, sulfur of 0.020 percent or less, and includes between 0.20 and 0.30 percent copper and between 0.20 and 0.50 percent cobalt. This steel is sold under proprietary names such as “GIN4 Mo.” The second excluded stainless steel strip in coils is similar to AISI 420-J2 and contains, by weight, carbon of between 0.62 and 0.70 percent, silicon of between 0.20 and 0.50 percent, manganese of between 0.45 and 0.80 percent, phosphorus of no more than 0.025 percent and sulfur of no more than 0.020 percent. This steel has a carbide density on average of 100 carbide particles per 100 square microns. An example of this product is “GIN5” steel. The third specialty steel has a chemical composition similar to AISI 420 F, with carbon of between 0.37 and 0.43 percent, molybdenum of between 1.15 and 1.35 percent, but lower manganese of between 0.20 and 0.80 percent, phosphorus of no more than 0.025 percent, silicon of between 0.20 and 0.50 percent, and sulfur of no more than 0.020 percent. This product is supplied with a hardness of more than Hv 500 guaranteed after customer processing, and is supplied as, for example, “GIN6.” 6 5 This list of uses is illustrative and provided for descriptive purposes only. 6 “GIN4 Mo,” “GIN5” and “GIN6” are the proprietary grades of Hitachi Metals America, Ltd. Analysis of Comments Received All issues raised in TKN's case brief and in Petitioners' rebuttal brief are addressed in the Memorandum to David M. Spooner, Assistant Secretary for Import Administration (Decision Memorandum), dated December 6, 2006, which is hereby adopted by this notice. A list of the issues which parties have raised and to which we have responded, all of which are in the Decision Memorandum, is attached to this notice as an appendix. The Decision Memorandum is on file in room B-099 of the main Department of Commerce building. In addition, a complete version of the Decision Memorandum can be accessed directly on the Internet at http://www.ia.ita.doc.gov/frn/index.html. The paper copy and electronic version of the Decision Memorandum are identical in content. Changes Since the Preliminary Results Based on our analysis of comments received, we have made changes to the margin calculation. The changes are listed below: 1. For the preliminary results, we inadvertently treated indirect selling expenses incurred in Mexico on TKN's behalf as U.S. indirect selling expenses, and deducted them from CEP. For these final results, we have treated these expenses properly as foreign indirect selling expenses and have not deducted them from CEP. See Decision Memorandum at Comment 1. 2. For the preliminary results we miscalculated the home market

(HM)costs used in the CEP profit calculation by failing to convert HM quantity from metric tons to hundredweight. This had the effect of overstating the CEP profit rate and CEP profit, which is deducted from CEP. For these final results, we have recalculated these CM costs and CEP profit using the correct quantity amounts. See Decision Memorandum at Comment 2. Final Results of the Review We determine the following percentage weighted-average margin exists for the period July 1, 2004, through June 30, 2005: Manufacturer / Exporter Weighted Average Margin (percentage) TKN 2.45 Assessment The Department shall determine, and U.S. Bureau of Customs and Border Protection

(CBP)shall assess, antidumping duties on all appropriate entries. In accordance with 19 CFR 351.212(b)(1), the Department calculates an assessment rate for each importer of the subject merchandise. Upon issuance of the final results of this review, if any importer-specific assessment rates calculated in the final results are above *de minimis* ( *i.e.* , at or above 0.5 percent), we will issue appraisement instructions directly to CBP to assess antidumping duties on appropriate entries by applying the assessment rate to the entered value of the merchandise. To determine whether the duty-assessment rate covering the period is *de minimis* , in accordance with the requirement set forth in 19 CFR 351.106(c)(2), we have calculated an importer-specific assessment *ad valorem* rate by aggregating the dumping margins calculated for all U.S. sales to each customer or importer and dividing this amount by the total entered value of these sales. Where the importer-specific *ad valorem* rate is greater than *de minimis* , and where the respondent has reported reliable entered values, we instruct CBP to apply the assessment rate to the entered value of the importer's entries during the POR. The Department intends to issue assessment instructions to CBP 15 days after the date of publication of the final results of review. The Department clarified its “automatic assessment” regulation on May 6, 2003. *See Antidumping and Countervailing Duty Proceedings: Assessment of Antidumping Duties* , 68 FR 23954 (May 6, 2003) ( *Assessment of Antidumping Duties* ). This clarification will apply to entries of subject merchandise during the period of review produced by the respondent for which it did not know its merchandise was destined for the United States. In such instances, we will instruct CBP to liquidate unreviewed entries at hte all-others rate if there is no rate for the intermediate company (or companies) involved in the transaction. For a full discussion of this clarification, *see Assessment of Antidumping Duties* . Cash Deposit Requirements The following deposit requirements will be effective upon publication of this notice of final results of administrative review for all shipments of stainless steel sheet and strip in coils from Germany entered, or withdrawn from warehouse, for consumption on or after the date of publication, as provided by section 751(a)(1) of the Tariff Act of 1930, as amended (the Tariff Act):

(1)the cash deposit rate for the reviewed company will be the rate shown above;

(2)for previously reviewed or investigated companies not listed above, the cash deposit rate will continue to be the company-specific rate published for the most recent period;

(3)if the exporter is not a firm covered in this review, a prior review, or the original less-than-fair-value

(LTFV)investigation, but the manufacturer is, the cash deposit rate will be the rate established for the most recent period for the manufacturer of the merchandise; and

(4)the cash deposit rate for all other manufacturers or exporters will continue to be 13.48 percent. This rate is the “All Others” rate from the amended final determination in the LTFV investigation of stainless steel sheet and strip in coils from Germany. *See Stainless Steel Sheet and Strip in Coils From Germany: Amended Final Determination of Antidumping Duty Investigation* , 67 FR 15178, 15179 (March 29, 2002). These deposit requirements shall remain in effect until publication of the final results of the next administrative review. Reimbursement This notice also serves as a final reminder to importers of their responsibility under 19 CFR 351.402(f) to file a certificate regarding the reimbursement of antidumping or countervailing duties prior to liquidation of the relevant entries during this review period. Failure to comply with this requirement could result in the Secretary's presumption that reimbursement of antidumping or countervailing duties occurred and the subsequent assessment of doubled antidumping duties. Notification Regarding Administrative Protective Orders This notice also serves as a reminder to parties subject to administrative protective orders

(HM)indirect selling expenses beyond the amount allowed under the CEP offset. 4. Whether the Department should allow non-dumped sales to offset dumped sales in its margin calculation (zeroing) [FR Doc. E6-21197 Filed 12-12-06; 8:45 am] BILLING CODE 3510-DS-S DEPARTMENT OF COMMERCE International Trade Administration (A-449-804) Notice of Final Results of Antidumping Duty Administrative Review: Steel Concrete Reinforcing Bars from Latvia AGENCY: Import Administration, International Trade Administration, Department of Commerce. SUMMARY: On August 8, 2006, the Department of Commerce (the Department) published the preliminary results of its fourth administrative review of the antidumping duty order on steel concrete reinforcing bars (rebar) from Latvia. The review covers one producer of the subject merchandise. The period of review

(POR)is September 1, 2004, through August 31, 2005. Based on our analysis of comments received, these final results differ from the preliminary results. The final results are listed below in the *Final Results of Review* section. EFFECTIVE DATE: December 13, 2006. FOR FURTHER INFORMATION CONTACT: Saliha Loucif at

(202)482-1779 or Julie Santoboni at

(202)482-4194; AD/CVD Operations, Office 1, Import Administration, International Trade Administration, U.S. Department of Commerce, 14 th Street & Constitution Avenue, NW, Washington, DC 20230. Supplementary Information: Background On August 8, 2006, the Department published in the **Federal Register** the preliminary results of the fourth administrative review of the antidumping duty order on rebar from Latvia. *See Notice of Preliminary Results of Antidumping Duty Administrative Review: Steel Concrete Reinforcing Bars from Latvia* , 71 FR 45031 (August 8, 2006) ( *Preliminary Results* ). We invited parties to comment on the *Preliminary Results* . On September 7, 2006, we received case briefs from the sole respondent, Joint Stock Company Liepajas Metalurgs (LM), and from the petitioners, the Rebar Trade Action Coalition

(RTAC)and its individual members. 1 No interested party requested a hearing during this review. 1 Commercial Metals Company, Gerdau Ameristeel Corporation, and Nucor Corporation are the members of RTAC. Scope of the Order The product covered by this order is all steel concrete reinforcing bars sold in straight lengths, currently classifiable in the Harmonized Tariff Schedule of the United States (HTSUS) under item numbers 7214.20.00, 7228.30.8050, 7222.11.0050, 7222.30.0000, 7228.60.6000, 7228.20.1000, or any other tariff item number. Specifically excluded are plain rounds (i.e., non-deformed or smooth bars) and rebar that has been further processed through bending or coating. HTSUS subheadings are provided for convenience and customs purposes. The written description of the scope of the order is dispositive. Analysis of Comments Received The issues raised in the briefs by parties to this administrative review are addressed in the *Issues and Decision Memorandum* to David M. Spooner, Assistant Secretary for Import Administration, from Stephen J. Claeys, Deputy Assistant Secretary ( *Decision Memorandum* ), dated December 6, 2006, which is hereby adopted by this notice. A list of the issues addressed in the *Decision Memorandum* is appended to this notice. The *Decision Memorandum* is on file in Room B-099 of the main Department building, and can also be accessed directly on the Web at *http://ia.ita.doc.gov/frn/index.html* . The paper copy and electronic version of the *Decision Memorandum* are identical in content. Changes Since the Preliminary Results Based on our analysis of comments received, we adjusted the calculation methodology used in the *Preliminary Results* . First, we calculated general and administrative expenses (G&A) and interest expenses based on LM's financial statements for the Fiscal Year 2005, which is the time period that most closely corresponds to the POR. Second, we moved expenses for LM's football and hockey clubs from G&A expenses to indirect selling expenses because these clubs provide indirect advertising benefits to the company. Finally, we adjusted the calculation of the variable cost of manufacturing in the margin calculation program to account for a clerical error. These adjustments are discussed in detail in the *Decision Memorandum* . Final Results of Review As a result of our review, we determine that the following weighted-average margin exists for the period of September 1, 2004, through August 31, 2005: Producer Weighted-Average Margin (Percentage) Joint Stock Company Liepajas Metalurgs 5.94 Assessment The Department will determine, and U.S. Customs and Border Protection

(CBP)shall assess, antidumping duties on all appropriate entries, pursuant to 19 CFR 351.212(b). The Department calculated importer-specific duty assessment rates on the basis of the ratio of the total amount of antidumping duties calculated for the examined sales to the total entered value of the examined sales for that importer. Where the assessment rate is above *de minimis* , we will instruct CBP to assess duties on all entries of subject merchandise by that importer. The Department intends to issue assessment instructions to CBP 15 days after the date of publication of these final results of review. The Department clarified its “automatic assessment” regulation on May 6, 2003 (68 FR 23954). This clarification will apply to entries of subject merchandise during the POR produced by companies included in these preliminary results of review for which the reviewed companies did not know their merchandise was destined for the United States. In such instances, the Department will instruct CBP to liquidate unreviewed entries at the all-others rate if there is no rate for the intermediate company(ies) involved in the transaction. For a full discussion of this clarification, *see Antidumping and Countervailing Duty Proceedings: Assessment of Antidumping Duties* , 68 FR 23954 (May 6, 2003). Cash Deposits Furthermore, the following deposit requirements will be effective upon publication of the final results of this administrative review for all shipments of rebar from Latvia entered, or withdrawn from warehouse, for consumption on or after the publication date of these final results, as provided by section 751(a) of the Tariff Act of 1930, as amended (the Act):

(1)For LM, the cash deposit rate will be 5.94 percent;

(2)for merchandise exported by producers or exporters not covered in this review but covered in a previous segment of this proceeding, the cash deposit rate will continue to be the company-specific rate published in the most recent final results in which that producer or exporter participated;

(3)if the exporter is not a firm covered in this review or in any previous segment of this proceeding, but the producer is, the cash deposit rate will be that established for the producer of the merchandise in these final results of review or in the most recent final results in which that producer participated; and

(4)if neither the exporter nor the producer is a firm covered in this review or in any previous segment of this proceeding, the cash deposit rate will be 17.21 percent, the “All Others” rate established in the less-than-fair-value investigation. These deposit requirements shall remain in effect until publication of the final results of the next administrative review. This notice also serves as a final reminder to importers of their responsibility under 19 CFR 351.402(f) to file a certificate regarding the reimbursement of antidumping duties prior to liquidation of the relevant entries during this review period. Failure to comply with this requirement could result in the Secretary's presumption that reimbursement of antidumping duties occurred, and in the subsequent assessment of double antidumping duties. This notice also is the only reminder to parties subject to administrative protective order

(APO)of their responsibility concerning the return or destruction of proprietary information disclosed under APO in accordance with 19 CFR 351.305. Timely written notification of the return/destruction of APO materials or conversion to judicial protective order is hereby requested. Failure to comply with the regulations and the terms of an APO is a sanctionable violation. We are issuing and publishing these results and notice in accordance with sections 751(a)(1) and 777(i)(1) of the Act. Dated: December 6, 2006. David M. Spooner, Assistant Secretary for Import Administration. Appendix *Comment 1:* Use of Monthly Cost Comparison Periods *Comment 2:* Date of Sale *Comment 3:* General and Administrative Expense Ratio Calculation *Comment 4:* Clerical Error *Comment 5:* Treatment of Non-Dumped Sales *Comment 6:* Financial Statements Used for General and Administrative Expenses and Interest Expenses [FR Doc. E6-21205 Filed 12-12-06; 8:45 am] BILLING CODE 3510-DS-S ENVIRONMENTAL PROTECTION AGENCY [EPA-HQ-OPP-2006-0987; FRL-8107-9] FIFRA Scientific Advisory Panel; Notice of Public Meeting AGENCY: Environmental Protection Agency (EPA). ACTION: Notice. SUMMARY: There will be a 2-day meeting of the Federal Insecticide, Fungicide, and Rodenticide Act Scientific Advisory Panel (FIFRA SAP) to consider and review the status of the *in utero* through lactational assay in the Endocrine Disruptor Screening Program (EDSP). DATES: The meeting will be held on February 27-28, 2007, from 8:30 a.m. to 5 p.m, eastern time. *Comments* : The Agency encourages submission of written comments by February 13, 2007 and requests for oral comments by February 20, 2007. However, written comments and requests to make oral comments may be submitted until the date of the meeting. For additional instructions, see Unit I.C. of the SUPPLEMENTARY INFORMATION . *Nominations* : Nominations of candidates to serve as ad hoc members of the FIFRA SAP for this meeting should be provided on or before December 26, 2006. *Special Accommodations* : For information on access or services for individuals with disabilities, and to request accommodation of a disability, please contact the Designated Federal Official

(DFO)listed under FOR FURTHER INFORMATION CONTACT at least 10 days prior to the meeting to give EPA as much time as possible to process your request. ADDRESSES: The meeting will be held at the Environmental Protection Agency, Conference Center - Lobby Level, One Potomac Yard (South Bldg.), 2777 S. Crystal Drive, Arlington, VA 22202. *Comments* : Submit your comments, identified by docket ID number EPA-HQ-OPP-2006-0987, by one of the following methods: • *Federal eRulemaking Portal: http://www.regulations.gov* . Follow the on-line instructions for submitting comments. Your use of the Federal eRulemaking Portal to submit comments to EPA electronically is EPA's preferred method for receiving comments. • *Mail* : Office of Pesticide Programs

(OPP)Regulatory Public Docket (7502P), Environmental Protection Agency, 1200 Pennsylvania Ave., N.W., Washington, DC 20460-0001. • *Delivery* : OPP Regulatory Public Docket (7502P), Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South Bldg), 2777 S. Crystal Drive, Arlington, VA. Deliveries are only accepted during the Docket's normal hours of operation (8:30 a.m. to 4 p.m., Monday through Friday, excluding legal holidays). Special arrangements should be made for deliveries of boxed information. The Docket telephone number is

(703)305-5805. *Instructions* : Direct your comments to docket ID number EPA-HQ-OPP-2006-0987. If your comments contain any information that you consider to be CBI or otherwise protected, please contact the DFO listed under FOR FURTHER INFORMATION CONTACT to obtain special instruction before submitting your comments. EPA's policy is that all comments received will be included in the docket without change and may be made available on-line at *http://www.regulations.gov* , including any personal information provided, unless the comment includes information claimed to be Confidential Business Information

(CBI)or other information whose disclosure is restricted by statute. Do not submit information that you consider to be CBI or otherwise protected through regulations.gov or e-mail. The regulations.gov website is an “anonymous access” system, which means EPA will not know your identity or contact information unless you provide it in the body of your comment. If you send an e-mail comment directly to EPA without going through regulations.gov, your e-mail address will be automatically captured and included as part of the comment that is placed in the docket and made available on the Internet. If you submit an electronic comment, EPA recommends that you include your name and other contact information in the body of your comment and with any disk or CD ROM you submit. If EPA cannot read your comment due to technical difficulties and cannot contact you for clarification, EPA may not be able to consider your comment. Electronic files should avoid the use of special characters, any form of encryption, and be free of any defects or viruses. *Docket* : All documents in the docket are listed in a docket index that is available at *http://www.regulations.gov.* Although listed in a docket index, some information is not publicly available, e.g., CBI or other information whose disclosure is restricted by statute. Certain other material, such as copyrighted material, is not placed on the Internet and will be publicly available only in hard copy form. Publicly available docket materials are available in the electronic docket at *http://www.regulations.gov* , or, if only available in hard copy, at the OPP Regulatory Public Docket in Rm. S-4400, One Potomac Yard (South Bldg), 2777 S. Crystal Drive, Arlington, VA. The hours of operation of this Docket Facility are from 8:30 a.m. to 4 p.m., Monday through Friday, excluding legal holidays. The Docket telephone number is

(703)305-5805. *Nominations, requests to present oral comments, and requests for special accommodations* : Submit nominations to serve as an ad hoc member of the FIFRA SAP, requests for special seating accommodations, or requests to present oral comments to the DFO listed under FOR FURTHER INFORMATION CONTACT . FOR FURTHER INFORMATION CONTACT: William Wooge, DFO, Office of Science Coordination and Policy (7201M), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460; telephone number: 202-564-8476; fax number: 202-564-8382; e-mail addresses: *wooge.william@epa.gov* . SUPPLEMENTARY INFORMATION: I. General Information A. Does this Action Apply to Me? This action is directed to the public in general. This action may, however, be of interest to persons who are or may be required to conduct testing of chemical substances under the Federal Food, Drug, and Cosmetic Act (FFDCA), FIFRA, and the Food Quality Protection Act of 1996 (FQPA). Since other entities may also be interested, the Agency has not attempted to describe all the specific entities that may be affected by this action. If you have any questions regarding the applicability of this action to a particular entity, consult the DFO listed under FOR FURTHER INFORMATION CONTACT . B. What Should I Consider as I Prepare My Comments for EPA? *Tips for preparing your comments* . When submitting comments, remember to: 1. Identify the document by docket ID number and other identifying information (subject heading, **Federal Register** date and page number). 2. Follow directions. The Agency may ask you to respond to specific questions or organize comments by referencing a Code of Federal Regulations

(CFR)part or section number. 3. Explain why you agree or disagree; suggest alternatives and substitute language for your requested changes. 4. Describe any assumptions and provide any technical information and/or data that you used. 5. If you estimate potential costs or burdens, explain how you arrived at your estimate in sufficient detail to allow for it to be reproduced. 6. Provide specific examples to illustrate your concerns and suggest alternatives. 7. Explain your views as clearly as possible, avoiding the use of profanity or personal threats. 8. Make sure to submit your comments by the comment period deadline identified. C. How May I Participate in this Meeting? You may participate in this meeting by following the instructions in this unit. To ensure proper receipt by EPA, it is imperative that you identify docket ID number EPA-HQ-OPP-2006-0987 in the subject line on the first page of your request. 1. *Written comments* . The Agency encourages that written comments be submitted, using the instructions in ADDRESSES , no later than February 13, 2007, to provide FIFRA SAP the time necessary to consider and review the written comments. However, written comments are accepted until the date of the meeting. Persons wishing to submit written comments at the meeting should contact the DFO listed under FOR FURTHER INFORMATION CONTACT and submit 30 copies. There is no limit on the extent of written comments for consideration by FIFRA SAP. 2. *Oral comments* . The Agency encourages that each individual or group wishing to make brief oral comments to the FIFRA SAP submit their request to the DFO listed under FOR FURTHER INFORMATION CONTACT no later than February 20, 2007, in order to be included on the meeting agenda. Requests to present oral comments will be accepted until the date of the meeting and, to the extent that time permits, the Chair of the FIFRA SAP may permit the presentation of oral comments at the meeting by interested persons who have not previously requested time. The request should identify the name of the individual making the presentation, the organization (if any) the individual will represent, and any requirements for audiovisual equipment (e.g., overhead projector, 35 mm projector, chalkboard). Oral comments before FIFRA SAP are limited to approximately 5 minutes unless prior arrangements have been made. In addition, each speaker should bring 30 copies of his or her comments and presentation slides for distribution to the FIFRA SAP at the meeting. 3. *Seating at the meeting* . Seating at the meeting will be on a first-come basis. 4. *Request for nominations to serve as ad hoc members of the FIFRA SAP for this meeting* . As part of a broader process for developing a pool of candidates for each meeting, the FIFRA SAP staff routinely solicits the stakeholder community for nominations of prospective candidates for service as ad hoc members of the FIFRA SAP. Any interested person or organization may nominate qualified individuals to be considered as prospective candidates for a specific meeting. Individuals nominated for this meeting should have expertise in one or more of the following areas: Mammalian

(rat)reproductive endocrinology and developmental and reproductive toxicology. Nominees should be scientists who have sufficient professional qualifications, including training and experience, to be capable of providing expert comments on the scientific issues for this meeting. Nominees should be identified by name, occupation, position, address, and telephone number. Nominations should be provided to the DFO listed under FOR FURTHER INFORMATION CONTACT on or before December 26, 2006. The Agency will consider all nominations of prospective candidates for this meeting that are received on or before this date. However, final selection of ad hoc members for this meeting is a discretionary function of the Agency. The selection of scientists to serve on the FIFRA SAP is based on the function of the panel and the expertise needed to address the Agency's charge to the panel. No interested scientists shall be ineligible to serve by reason of their membership on any other advisory committee to a Federal department or agency or their employment by a Federal department or agency except the EPA. Other factors considered during the selection process include availability of the potential panel member to fully participate in the panel's reviews, absence of any conflicts of interest or appearance of lack of impartiality, independence with respect to the matters under review, and lack of bias. Though financial conflicts of interest, the appearance of lack of impartiality, lack of independence, and bias may result in disqualification, the absence of such concerns does not assure that a candidate will be selected to serve on the FIFRA SAP. Numerous qualified candidates are identified for each panel. Therefore, selection decisions involve carefully weighing a number of factors including the candidates' areas of expertise and professional qualifications and achieving an overall balance of different scientific perspectives on the panel. In order to have the collective breadth of experience needed to address the Agency's charge for this meeting, the Agency anticipates selecting approximately 10 ad hoc scientists. If a prospective candidate for service on the FIFRA SAP is considered for participation in a particular session, the candidate is subject to the provisions of 5 CFR part 2634, Executive Branch Financial Disclosure, as supplemented by the EPA in 5 CFR part 6401. As such, the FIFRA SAP candidate is required to submit a Confidential Financial Disclosure Form for Special Government Employees Serving on Federal Advisory Committees at the U.S. Environmental Protection Agency (EPA Form 3110-48 [5-02]) which shall fully disclose, among other financial interests, the candidate's employment, stocks and, bonds, and where applicable, sources of research support. The EPA will evaluate the candidates financial disclosure form to assess whether there are financial conflicts of interest, appearance of a lack of impartiality or any prior involvement with the development of the documents under consideration (including previous scientific peer review) before the candidate is considered further for service on the FIFRA SAP. Those who are selected from the pool of prospective candidates will be asked to attend the public meetings and to participate in the discussion of key issues and assumptions at these meetings. In addition, they will be asked to review and to help finalize the meeting minutes. The list of FIFRA SAP members participating at this meeting will be posted on the FIFRA SAP web site at *http://epa.gov/scipoly/sap* or may be obtained from the OPP Regulatory Public Docket at *http://www.regulations.gov* . II. Background A. Purpose of the FIFRA SAP The FIFRA SAP serves as the primary scientific peer review mechanism of the United States Environmental Protection Agency (EPA), Office of Prevention, Pesticides and Toxic Substances and is structured to provide scientific advice, information and recommendations to the EPA Administrator on pesticides and pesticide-related issues as to the impact of regulatory actions on health and the environment. The FIFRA SAP is a Federal advisory committee established in 1975 under the Federal Insecticide, Fungicide and Rodenticide Act that operates in accordance with requirements of the Federal Advisory Committee Act. The FIFRA SAP is composed of a permanent panel consisting of seven members who are appointed by the EPA Administrator from nominees provided by the National Institutes of Health and the National Science Foundation. FIFRA, as amended by the 1996 Food Quality Protection Act, established a Science Review Board consisting of at least 60 scientists who are available to the Scientific Advisory Panel on an ad hoc basis to assist in reviews conducted by the Panel. As a peer review mechanism, the FIFRA SAP provides comments, evaluations and recommendations to improve the effectiveness and quality of analyses made by Agency scientists. Members of the FIFRA SAP are scientists who have sufficient professional qualifications, including training and experience, to provide expert advice and recommendations to the Agency. B. Public Meeting The EPA is implementing the Endocrine Disruptor Screening Program

(EDSP)in response to a 1996 Congressional mandate in the Federal Food, Drug, and Cosmetic Act (FFDCA) to establish a screening program using validated assays to identify pesticides that may have estrogenic effects in humans and other endocrine effects, as designated by the EPA Administrator. The Agency also has authority to include other non-pesticide chemicals that have an effect cumulative to that of a pesticide to which a substantial human population may be exposed. In developing the EDSP, the EPA considered the recommendations of the Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC), a panel chartered pursuant to the Federal Advisory Committee Act (FACA). The screening program was also reviewed by EPA's Science Advisory Board and by the Scientific Advisory Panel (SAB/SAP), as required by the FFDCA. It was recommended that the EPA address both human and ecological effects and examine effects to estrogen, androgen, and thyroid

(EAT)related processes, and that a two-tiered approach be used for screening. The purpose of the Tier-1 battery is to identify substances that have the potential to interact with the endocrine system. The purpose of Tier 2 is to confirm the interaction, identify any adverse effects, and establish quantitative relationships between dose and adverse effects. Both the EDSTAC and SAB/SAP recognized the importance of chemical exposure during development *in utero* as well as during lactation and, therefore, recommended an *in utero* through lactational animal model to detect effects that may result from pre- and postnatal exposure. The EDSTAC and SAB/SAP also recommended that any *in utero* through lactational bioassay should be developed in a way that would allow for replacement of one or more of the other assays proposed for the Tier-1 screening battery. The EDSP commissioned an *in utero* through lactational Detailed Review Paper

(DRP)that consisted of an extensive review of the scientific literature regarding chemicals known to disrupt the EAT hormone systems during pre- and postnatal development. The DRP presented three *in utero* through lactational bioassay protocols for the EDSP to consider. The EPA presented the DRP and its recommendations to the Endocrine Disruptor Methods Validation Subcommittee (EDMVS) for review and discussion. The most comprehensive of the three protocols was chosen and tested with methoxychlor, a positive compound that is known to have estrogenic, anti-estrogenic and anti-androgenic effects. In general, the EDMVS agreed with this pre-validation approach with the expectation that the EPA would return to a federal advisory committee such as the SAP to review and discuss the results of the *in utero* through lactational study with methoxychlor. The purpose of this meeting is to allow the SAP to review and discuss the protocol and assay results of an *in utero* through lactational study with methoxychlor within the current context of the EDSP and to provide advice that will inform the EPA's decision to continue, modify or suspend the development of an *in utero* through lactational bioassay as a screening assay in a Tier-1 battery. C. FIFRA SAP Documents and Meeting Minutes. EPA's background materials, charge/questions to the FIFRA SAP, FIFRA SAP composition (i.e., members and ad hoc members for this meeting), and the meeting agenda will be available by late January 2007. In addition, the Agency may provide additional background documents as the materials become available. You may obtain electronic copies of these documents, and certain other related documents that might be available electronically, at http://www.regulations.gov and the FIFRA SAP homepage at *http://www.epa.gov/scipoly/sap.* The FIFRA SAP will prepare meeting minutes summarizing its recommendations to the Agency approximately 90 days after the meeting. The meeting minutes will be posted on the FIFRA SAP web site or may be obtained from the OPP Regulatory Public Docket at *http://www.regulations.gov.* List of Subjects Environmental protection, Pesticides and pests. Dated: December 7, 2006. Elizabeth A. Resek, Director, Office of Science Coordination and Policy. [FR Doc. E6-21201 Filed 12-12-06; 8:45 am] BILLING CODE 6560-50-S ENVIRONMENTAL PROTECTION AGENCY [EPA-HQ-OPP-2005-0098; FRL-8107-1] Ethyl Parathion; Product Cancellation Order AGENCY: Environmental Protection Agency (EPA). ACTION: Notice. SUMMARY: This notice announces EPA's order for the cancellations, voluntarily requested by the Drexel Chemical Company and accepted by the Agency, of products containing the pesticide ethyl parathion, pursuant to section 6(f)(1) of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), as amended. This cancellation order follows April 27, 2005 **Federal Register** Notice of Receipt of Requests from the ethyl parathion registrant to voluntarily cancel all their ethyl parathion product registrations. These are the last ethyl parathion products registered for use in the United States. In the April 27, 2005 Notice, EPA indicated that it would issue an order implementing the cancellations and/or amendments to terminate uses, unless the Agency received substantive comments within the 30-day comment period that would merit its further review of these requests, or unless the registrants withdrew their requests within this period. The Agency did not receive any comments on the Notice. Further, the registrant did not withdraw their requests. Accordingly, EPA hereby issues in this notice a cancellation order granting the requested cancellations. Any distribution, sale, or use of the ethyl parathion products subject to this cancellation order is permitted only in accordance with the terms of this order, including any existing stocks provisions. DATES: The cancellations are effective December 13, 2006. FOR FURTHER INFORMATION CONTACT: Laura Parsons, Special Review and Reregistration Division (7508P), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number:

(703)305-5776; fax number:

(703)305-8005; e-mail address: *parsons.laura@epa.gov* . SUPPLEMENTARY INFORMATION: I. General Information A. Does this Action Apply to Me? This action is directed to the public in general, and may be of interest to a wide range of stakeholders including environmental, human health, and agricultural advocates; the chemical industry; pesticide users; and members of the public interested in the sale, distribution, or use of pesticides. Since others also may be interested, the Agency has not attempted to describe all the specific entities that may be affected by this action. If you have any questions regarding the applicability of this action to a particular entity, consult the person listed under FOR FURTHER INFORMATION CONTACT. B. How Can I Get Copies of this Document and Other Related Information? 1. *Docket.* EPA has established a docket for this action under docket identification

(ID)number EPA-HQ-OPPT-2005-0098. Publicly available docket materials are available either in the electronic docket at *http://www.regulations.gov* , or, if only available in hard copy, at the Office of Pesticide Programs

(OPP)Regulatory Public Docket in Rm. S-4400, One Potomac Yard (South Building), 2777 S. Crystal Drive Arlington, VA. The hours of operation of this Docket Facility are from 8:30 a.m. to 4 p.m., Monday through Friday, excluding legal holidays. The Docket telephone number is

(703)305-5805. 2. *Electronic access* . You may access this **Federal Register** document electronically through the EPA Internet under the **Federal Register** listings at *http://www.epa.gov/fedrgstr/* . II. What Action is the Agency Taking? This notice announces the cancellation, as requested by registrants, of all end-use and manufacturing-use ethyl parathion products registered under section 3 of FIFRA. These registrations are listed in sequence by registration number in Table 1 of this unit. **Table 1.—Ethyl Parathion Product Cancellations** EPA Registration No. Product Name 19713-322 Drexel Seis-TRES 6-3 19713-323 Drexel Parathion 8 19713-324 IDA Seis-Tres 6-3 19713-325 Drexel Parathion 4 EC Table 2 of this unit includes the name and address of record for the registrant of the products in Table 1 of this unit. **Table 2.—Registrant of Cancelled Ethyl Parathion Products** EPA Company No. Company Name and Address 19713 Drexel Chemical Company 1700 Channel Avenue P.O. Box 13327 Memphis, TN 38113-0327 III. Summary of Public Comments Received and Agency Response to Comments During the public comment period provided, EPA received no comments in response to the April 27, 2005 **Federal Register** (70 FR 21761; FRL-7709-8) notice announcing the Agency's receipt of the request for voluntary cancellations. IV. Cancellation Order Pursuant to FIFRA section 6(f), EPA hereby approves the requested cancellations of ethyl parathion registrations identified in Table 1 of Unit II. Accordingly, the Agency orders that the ethyl parathion product registrations identified in Table 1 of Unit II. are hereby canceled. Any distribution, sale, or use of existing stocks of the products identified in Table 1 of Unit II. in a manner inconsistent with any of the Provisions for Disposition of Existing Stocks set forth in Unit VI. will be considered a violation of FIFRA. V. What is the Agency's Authority for Taking this Action? Section 6(f)(1) of FIFRA provides that a registrant of a pesticide product may at any time request that any of its pesticide registrations be canceled or amended to terminate one or more uses. FIFRA further provides that, before acting on the request, EPA must publish a notice of receipt of any such request in the **Federal Register** . Thereafter, following the public comment period, the Administrator may approve such a request. VI. Provisions for Disposition of Existing Stocks Existing stocks are those stocks of registered pesticide products which are currently in the United States and which were packaged, labeled, and released for shipment prior to the effective date of the cancellation action. The cancellation order issued in this Notice includes the following existing stocks provisions. Because no product has been produced, sold or distributed for several years, the prohibition on sales, distribution and use of existing stocks is effective immediately. List of Subjects Environmental protection, Pesticides and pests. Dated: December 4, 2006. Debra Edwards, Director, Special Review and Reregistration Division, Office of Pesticide Programs. [FR Doc. E6-20988 Filed 12-12-06; 8:45 am] BILLING CODE 6560-50-S ENVIRONMENTAL PROTECTION AGENCY [EPA-HQ-OPP-2002-0202; FRL-8103-4] Lindane; Cancellation Order AGENCY: Environmental Protection Agency (EPA). ACTION: Notice. SUMMARY: This notice announces EPA's issuance of final orders cancelling the registrations of all pesticide products containing the pesticide lindane. The cancellation orders followed the August 23, 2006 **Federal Register** Notice of Receipt of Requests (71 FR 49445) (FRL-8089-1) from the lindane registrants to voluntarily cancel their lindane product registrations and announcing the commencement of a public comment period as required by section 6(f)(1) of the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA). In the August 23, 2006 notice, EPA indicated that it would issue an order implementing the cancellations to terminate uses unless the Agency received substantive comments within the 30-day comment period that would merit its further review of these requests, or unless the registrant(s) withdrew their request(s) within this period. The Agency did not receive any comments that required further review of the cancellation requests. Further, the registrants did not withdraw their requests. Accordingly, EPA sent final cancellation orders to the registrants granting the requested cancellations. Any distribution, sale, or use of the lindane products subject to these cancellation orders is permitted only in accordance with the terms of the existing stocks provisions in the cancellation orders and described in Unit VI. DATES: Cancellation of manufacturing-use product registrations was effective on October 4, 2006, and the last date of use will be July 1, 2007. Cancellation of end-use product registrations will be effective on July 1, 2007, and the last date of use will be October 1, 2009. FOR FURTHER INFORMATION CONTACT: Mark T. Howard, Special Review and Reregistration Division (7508P), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number:

(703)308-8172; fax number:

(703)308-8005; e-mail address: *howard.markt@epa.gov* . SUPPLEMENTARY INFORMATION: I. General Information A. Does this Action Apply to Me? This action is directed to the public in general, and may be of interest to a wide range of stakeholders including environmental, human health, and agricultural advocates; the chemical industry; pesticide users; and members of the public interested in the sale, distribution, or use of pesticides. Since others also may be interested, the Agency has not attempted to describe all the specific entities that may be affected by this action. If you have any questions regarding the applicability of this action to a particular entity, consult the person listed under FOR FURTHER INFORMATION CONTACT . B. How Can I Get Copies of this Document and Other Related Information? 1. *Docket* . EPA has established a docket for this action under docket identification

(ID)number EPA-HQ-OPP-2002-0202. Publicly available docket materials are available either in the electronic docket at *http://www.regulations.gov* , or, if only available in hard copy, at the Office of Pesticide Programs

(OPP)Regulatory Public Docket in Rm. S-4400, One Potomac Yard (South Bldg.), 2777 S. Crystal Dr., Arlington, VA. The hours of operation of this Docket Facility are from 8:30 a.m. to 4 p.m., Monday through Friday, excluding legal holidays. The Docket telephone number is

(703)305-5805. 2. *Electronic access* . You may access this **Federal Register** document electronically through the EPA Internet under the **Federal Register** listings at *http://www.epa.gov/fedrgstr* . II. What Action is the Agency Taking? This notice announces the cancellation of registrations of all lindane products. These registrations are listed in sequence by registration number in Table 1 of this unit, along with the effective date of the cancellation and last date of use. **Table 1.—Lindane Product Cancellations** Registration No. Product name Company Effective Date of Cancellation Last Date of Use 400-490 Gustafson Flowable Lindane 40% Chemtura USA Corp. July 1, 2007 October 1, 2009 400-532 Sorghum Guard Chemtura USA Corp. July 1, 2007 October 1, 2009 400-538 Gustafson Lindane 30C Flowable Chemtura USA Corp. July 1, 2007 October 1, 2009 400-539 Gustafson Captan Lindane 12.5-25 Chemtura USA Corp. July 1, 2007 October 1, 2009 400-540 Gustafson Vitavax-Thiram-Lindane Flowable Fungicide Insecticide Chemtura USA Corp. July 1, 2007 October 1, 2009 554-140 DB-Green L AGSCO Inc. July 1, 2007 October 1, 2009 554-144 Lindane ST-40 AGSCO Inc July 1, 2007 October 1, 2009 19713-61 Lindane Technical Drexel Chemical Co. October 4, 2006 July 1, 2007 19713-191 Lindane Technical Drexel Chemical Co. October 4, 2006 July 1, 2007 19713-387 Lindane Flowable Drexel Chemical Co. July 1, 2007 October 1, 2009 19713-401 Lindane 30% Drexel Chemical Co. July 1, 2007 October 1, 2009 82378-1 Lindane Technical JLM International Inc. October 4, 2006 July 1, 2007 Table 2 of this unit includes the names and addresses of record for all registrants of the products in Table 1 of this unit, in sequence by EPA company number. **Table 2—Registrants of Cancelled Lindane Products** EPA Company No. Company Name and Address 400 Chemtura USA Corporation 199 Benson Road Middlebury, Connecticut 06749 540 AGSCO Inc. PO Box 13458 Grand Forks, North Dakota 58208-3458 19713 Drexel Chemical Co. 1700 Channel Avenue, PO Box 13327 Memphis, Tennessee 38113-0327 82378 JLM International Inc. 8675 Hidden River Parkway Tampa, Florida 33637 III. Summary of Public Comments Received and Agency Response to Comments The Agency received one comment from a children's advocacy group in favor of the cancellation. IV. Summary of Cancellation Orders Pursuant to FIFRA section 6(f)(1)(A), EPA granted the cancellation requests for the registrations identified in Table 1 of Unit II. Accordingly, the Agency ordered the cancellation of the manufacturing-use product registrations effective October 4, 2006. EPA ordered the cancellation of end-use product registrations effective July 1, 2007. Any distribution, sale, or use of existing stocks of the products identified in Table 1 in Unit II. in a manner inconsistent with any of the Provisions for Disposition of Existing Stocks set forth in Unit VI. and in the cancellation orders sent to the registrants will be considered a violation of FIFRA. Copies of the cancellation orders are in the docket. V. What is the Agency's Authority for Taking this Action? Section 6(f)(1) of FIFRA provides that a registrant of a pesticide product may at any time request that any of its pesticide registrations be canceled or amended to terminate one or more uses. FIFRA further provides that, before acting on the request, EPA must publish a notice of receipt of any such request in the **Federal Register** . Thereafter, following the public comment period, the Administrator may approve such a request. VI. Provisions for Disposition of Existing Stocks Cancellation of manufacturing-use product registrations was effective on October 4, 2006. Cancellation of end-use product registrations will be effective on July 1, 2007. Existing stocks are those stocks of registered pesticide products which are currently in the United States and which were packaged, labeled, and released for shipment prior to the effective date of the cancellation action. It would be a violation of FIFRA to distribute or sell any stocks currently in the United States which have been produced, packaged, labeled, or released for shipment after the effective dates of cancellation listed in this document. Existing stocks of the canceled products may be legally distributed or sold until the last date on which the product can be used, as specified in the cancellation orders, provided that use of existing stocks is consistent with the terms of the previously approved labeling on, or that accompanies, the modified product. For manufacturing-use products, the Agency has established in the canellation orders July 1, 2007, as the last day on which exisiting stocks of these products can be used. For end-use products, the Agency expects that existing stocks will be exhausted by October 1, 2009, and, as such, has established in the cancellation orders October 1, 2009, as the last day on which existing stocks of these products can be used. List of Subjects Environmental protection, Lindane, Pesticides and pests. Dated: December 4, 2006. Debra Edwards, Director, Special Review and Reregistration Division, Office of Pesticide Programs. [FR Doc. E6-21101 Filed 12-12-06; 8:45 am] BILLING CODE 6560-50-S ENVIRONMENTAL PROTECTION AGENCY [FRL-8254-8] Clean Water Act Section 303(d): Availability of 10 Total Maximum Daily Loads (TMDLs) AGENCY: Environmental Protection Agency (EPA). ACTION: Notice of availability. SUMMARY: This notice announces the availability of the administrative record file for comment on 10 TMDLs and the calculations for these TMDLs prepared by EPA Region 6 for waters listed in the state of Arkansas under section 303(d) of the Clean Water Act (CWA). These TMDLs were completed in response to the lawsuit styled *Sierra Club, et al.* v. *Browner, et al.,* No. LR-C-99-114. DATES: Comments must be submitted in writing to EPA on or before January 12, 2007. ADDRESSES: Comments on the 10 TMDLs should be sent to Ms. Diane Smith, Environmental Protection Specialist, Water Quality Protection Division, U.S. Environmental Protection Agency Region 6, 1445 Ross Ave., Dallas, TX 75202-2733, facsimile

(214)665-7373, or e-mail: *smith.diane@epa.gov.* For further information, contact Diane Smith at

(214)665-2145. Documents from the administrative record file for these TMDLs are available for public inspection at this address as well. Documents from the administrative record file may be viewed at *http://www.epa.gov/region6/6wq/npdes/tmdl/index.htm,* or obtained by calling

(214)665-2145 or writing Ms. Smith at the above address. Please contact Ms. Smith to schedule an inspection. FOR FURTHER INFORMATION CONTACT: Diane Smith at

(214)665-2145. SUPPLEMENTARY INFORMATION: In 1999, five Arkansas environmental groups, the Sierra Club, Federation of Fly Fishers, Crooked Creek Coalition, Arkansas Fly Fishers, and Save our Streams (plaintiffs), filed a lawsuit in Federal Court against the EPA, styled *Sierra Club, et al.* v. *Browner, et al.,* No. LR-C-99-114. Among other claims, plaintiffs alleged that EPA failed to establish Arkansas TMDLs in a timely manner. EPA proposes these TMDLs pursuant to a consent decree entered in this lawsuit. EPA Seeks Comments on 10 TMDLs By this notice EPA is seeking comment on the following 10 TMDLs for waters located within the state of Arkansas: Segment-Reach Waterbody Name Pollutant 08020203-625 Bear Creek Lake Nutrient. 08020203 Horseshoe Lake Nutrient. 08020204 Mallard Lake Nutrient. 08020302 Frierson Lake Turbidity. 08020303 Old Town Lake Nutrient. 08040203-904 Big Creek CBOD and Ammonia. 08050002 Grand Lake Nutrient. 11110204 Spring Lake Mercury. 11140201 First Old River Lake Nutrient. EPA requests that the public provide to EPA any water quality related data and information that may be relevant to the calculations for these 10 TMDLs. EPA will review all data and information submitted during the public comment period and revise the TMDLs and determinations where appropriate. EPA will then forward the TMDLs to the Arkansas Department of Environmental Quality (ADEQ). The ADEQ will incorporate the TMDLs into its current water quality management plan. Dated: December 6, 2006. James R. Brown, P.G., Acting Division Director, Water Quality Protection Division, Region 6. [FR Doc. E6-21200 Filed 12-12-06; 8:45 am] BILLING CODE 6560-50-P FEDERAL COMMUNICATIONS COMMISSION Notice of Public Information Collection(s) Being Submitted for Review to the Office of Management and Budget November 30, 2006. SUMMARY: The Federal Communications Commission, as part of its continuing effort to reduce paperwork burden invites the general public and other Federal agencies to take this opportunity to comment on the following information collection(s), as required by the Paperwork Reduction Act

(PRA)of 1995, Public Law 104-13. An agency may not conduct or sponsor a collection of information unless it displays a currently valid control number. No person shall be subject to any penalty for failing to comply with a collection of information subject to the Paperwork Reduction Act

(PRA)that does not display a valid control number. Comments are requested concerning

(a)whether the proposed collection of information is necessary for the proper performance of the functions of the Commission, including whether the information shall have practical utility;

(b)the accuracy of the Commission's burden estimate;

(c)ways to enhance the quality, utility, and clarity of the information collected; and

(PRA)comments should be submitted on or before January 12, 2007. If you anticipate that you will be submitting PRA comments but find it difficult to do so within the period of time allowed by this notice, you should advise the FCC contact listed below as soon as possible. ADDRESSES: Direct all PRA comments to Allison E. Zaleski, Office of Management and Budget, Room 10236 NEOB, Washington, DC 20503,

(202)395-6466, or via fax at

(202)395-5167 or via Internet at *Allison_E._Zaleski@eop.omb.gov* and to *Leslie_F._Smith@fcc.gov* , Federal Communications Commission, Room 1-C216, 445 12th Street, SW., Washington, DC 20554, or an e-mail to *PRA@fcc.gov* . If you would like to obtain or view a copy of this information collection, you may do so by visiting the FCC PRA Web page at: *http://www.fcc.gov/omd/pra* . FOR FURTHER INFORMATION CONTACT: For additional information or copies of the information collection(s), contact Leslie F. Smith at

(202)418-0217 or via the Internet at *Leslie.Smith@fcc.gov* . SUPPLEMENTARY INFORMATION: *OMB Control Number:* 3060-0773. *Title:* Section 2.803, Marketing of RF Devices Prior to Equipment Authorization. *Form Number:* N/A. *Type of Review:* Extension of a currently approved collection. *Respondents:* Businesses or other for-profit entities. *Number of Respondents:* 6,000. *Estimated Time per Response:* 0.5 hours. *Frequency of Response:* One time and on occasion reporting requirements; Third party disclosure. *Obligation To Respond:* Required to obtain or retain benefits. *Total Annual Burden:* 3,000 hours. *Total Annual Costs:* N/A. *Nature and Extent of Confidentiality:* There is no need for confidentiality. *Privacy Act Impact Assessment:* No impact(s). *Needs and Uses:* FCC rules permit the display and advertising of radio frequency

(RF)devices prior to equipment authorization or to a determination of compliance, providing that the advertising or display contains a conspicuous notice as specified at 47 CFR 2.803(c). A notice must also accompany RF prototype equipment devices offered for sale, as stated in 47 CFR 2.803(c)(1), prior to equipment authorization or to a showing of compliance, that the equipment is a prototype and is not for sale. This information informs third parties of the FCC's requirement for the responsible party to comply with its rules. Federal Communications Commission. Marlene H. Dortch, Secretary. [FR Doc. E6-20907 Filed 12-12-06; 8:45 am] BILLING CODE 6712-01-P FEDERAL COMMUNICATIONS COMMISSION Notice of Public Information Collection(s) Being Reviewed by the Federal Communications Commission for Extension Under Delegated Authority December 5, 2006. SUMMARY: The Federal Communications Commission, as part of its continuing effort to reduce paperwork burden invites the general public and other Federal agencies to take this opportunity to comment on the following information collection(s), as required by the Paperwork Reduction Act

(a)whether the proposed collection of information is necessary for the proper performance of the functions of the Commission, including whether the information shall have practical utility;

(b)the accuracy of the Commission's burden estimate;

(c)ways to enhance the quality, utility, and clarity of the information collected; and

(PRA)comments should be submitted on or before February 12, 2007. If you anticipate that you will be submitting comments, but find it difficult to do so within the period of time allowed by this notice, you should advise the contact listed below as soon as possible. ADDRESSES: You may submit your all Paperwork Reduction Act

(PRA)comments by e-mail or U.S. postal mail. To submit your comments by e-mail send them to *PRA@fcc.gov* . To submit your comments by U.S. mail, mark them to the attention of Cathy Williams, Federal Communications Commission, Room 1-C823, 445 12th Street, SW., Washington, DC 20554. FOR FURTHER INFORMATION CONTACT: For additional information about the information collection(s) send an e-mail to *PRA@fcc.gov* or contact Cathy Williams at

(202)418-2918. SUPPLEMENTARY INFORMATION: *OMB Control Number:* 3060-1040. *Title:* Broadcast Ownership Rules, Report and Order in MB Docket No. 02-277 and MM Docket Nos. 02-235, 02-327 and 00-244. *Form Number:* Not applicable. *Type of Review:* Extension of a currently approved collection. *Respondents:* Business or other for-profit entities. *Number of Respondents:* 12. *Estimated Time per Response:* 2-10 hours. *Frequency of Response:* One-time reporting requirement. *Obligation to Respond:* Required to obtain and retain benefits. *Total Annual Burden:* 12 hours. *Total Annual Cost:* None. *Privacy Impact Assessment:* No impact(s). *Nature and Extend of Confidentiality:* There is no need for confidentiality. *Needs and Uses:* On June 2, 2003, the Commission adopted a Report and Order and Notice of Proposed Rulemaking (R&O), In the Matter of 2002 Biennial Regulatory Review—Review of the Commission's Broadcast Ownership Rules and Other Rules Adopted Pursuant to Section 202 of the Telecommunications Act of 1996, MM Docket No. 02-277, Cross Ownership of Broadcast Stations and Newspapers, MM Docket No. 01-235, Rules and Policies Concerning Multiple Ownership of Radio Broadcast Stations in Local Markets, MM Docket No. 01-317, Definition of Radio Markets, MM Docket No. 00-244, and Definition of Radio Markets for Areas Not Located in an Arbitron Survey Areas Not Located in an Arbitron Survey Area, MB Docket No. 03-130, FCC 03-127. That R&O contained several one-time reporting requirements which were outside of form collections, affecting licensees with temporary waivers, conditional waivers, pending waiver requests, extensions of waiver, or requests for permanent waivers of the broadcast ownership rules. These reporting requirements were adopted to ensure compliance with the new broadcast ownership rules and to ensure the rules' effectiveness. Federal Communications Commission. Marlene H. Dortch, Secretary. [FR Doc. E6-20997 Filed 12-12-06; 8:45 am] BILLING CODE 6712-10-P FEDERAL COMMUNICATIONS COMMISSION Notice of Public Information Collection(s) Being Submitted for Review to the Office of Management and Budget December 1, 2006. SUMMARY: The Federal Communications Commission, as part of its continuing effort to reduce paperwork burden invites the general public and other Federal agencies to take this opportunity to comment on the following information collection(s), as required by the Paperwork Reduction Act

(PRA)that does not display a valid control number. Comments are requested concerning

(a)whether the proposed collection of information is necessary for the proper performance of the functions of the Commission, including whether the information shall have practical utility;

(b)the accuracy of the Commission's burden estimate;

(c)ways to enhance the quality, utility, and clarity of the information collected; and

(PRA)comments should be submitted on or before January 12, 2007. If you anticipate that you will be submitting PRA comments, but find it difficult to do so within the period of time allowed by this notice, you should advise the FCC contact listed below as soon as possible. ADDRESSES: Direct all PRA comments to Allison E. Zaleski, Office of Management and Budget, Room 10236 NEOB, Washington, DC 20503,

(202)395-6466, or via fax at 202-395-5167 or via Internet at *Allison_E._Zaleski@eop.omb.gov* and to *Judith-B.Herman@fcc.gov* , Federal Communications Commission, Room 1-B441, 445 12th Street, SW., Washington, DC 20554 or an e-mail to *PRA@fcc.gov* . If you would like to obtain or view a copy of this information collection, you may do so by visiting the FCC PRA Web page at: *http://www.fcc.gov/omd/pra* . FOR FURTHER INFORMATION CONTACT: For additional information or copies of the information collection(s), contact Judith B. Herman at 202-418-0214 or via the Internet at *Judith-B.Herman@fcc.gov* . SUPPLEMENTARY INFORMATION: *OMB Control Number:* 3060-0531. *Title:* Local Multipoint Distribution Service (LMDS). *Form No.:* N/A. *Type of Review:* Extension of a currently approved collection. *Respondents:* Business or other for-profit. *Number of Respondents:* 423 respondents; 423 responses. *Estimated Time per Response:* .25-20 hours. *Frequency of Response:* On occasion and every 10 year reporting requirements and third party disclosure requirement. *Obligation to Respond:* Required to obtain or retain benefits. *Total Annual Burden:* 6,394 hours. *Total Annual Cost:* $10,800. *Privacy Act Impact Assessment:* N/A. *Nature and Extent of Confidentiality:* There is no need for confidentiality. Respondents may request materials or information submitted to the Commission be withheld from public inspection under 47 CFR 0.459 of the Commission's rules. *Needs and Uses:* The Commission will submit this information collection to OMB as an extension (no change in reporting or third party disclosure requirements) after this 30 day comment period to obtain the full three-year clearance from them. This collection of information for Local Multipoint Distribution Service

(LMDS)is imposed on respondents pursuant to 47 CFR 101.103 and 101.1011. Pursuant to 47 CFR 101.1011, LMDS licensees must make a showing of substantial service in their license area within ten years of being licensed. A licensee must demonstrate that it provided service which is sound, favorable, and substantially above a level of mediocre service which might minimally warrant renewal. In order to do so, an LMDS licensee seeking renewal must submit a showing to explain why renewal of the license is warranted. At a minimum, this showing must include:

(1)A description of its current service in terms of geographic coverage and population served;

(2)an explanation of its record of expansion, including a timetable of new construction to meet changes in demand for service; and

(3)copies of all Commission rule or policy and a list of an pending proceedings that relate to any matter described directly above. Renewal applications must be filed once every ten years. The information is used by Commission staff in carrying out its duties to determine the technical, legal and other qualifications of applicants to operate and remain license to operate a station in the LMDS. Specifically, the frequency coordination information requested pursuant to section 101.103 is necessary to facilitate the rendition of communication service on an interference-free basis in each service area. The frequency coordination procedures ensure that LMDS applicants and licensees have the information necessary to cooperate in the selection and use of frequencies assigned in order to minimize interference and thereby obtain the most effective use of the spectrum. The information is also necessary for the Commission to resolve interference conflicts that cannot be settled between or among the affected applicants and licensees. For LMDS licensees seeking renewal, the information requested pursuant to section 101.1011 is necessary for the Commission staff to determine whether a licensee has provided sufficient evidence of substantial service during its license term and has substantially complied with the Communications Act and with applicable Commission rules and policies. Federal Communications Commission. Marlene H. Dortch, Secretary. [FR Doc. E6-20998 Filed 12-12-06; 8:45 am] BILLING CODE 6712-01-P FEDERAL COMMUNICATIONS COMMISSION Notice of Public Information Collection(s) Being Submitted to OMB for Review and Approval December 5, 2006. SUMMARY: The Federal Communications Commissions, as part of its continuing effort to reduce paperwork burden invites the general public and other Federal agencies to take this opportunity to comment on the following information collection, as required by the Paperwork Reduction Act of 1995, Public Law 104-13. An agency may not conduct or sponsor a collection of information unless it displays a currently valid control number. No person shall be subject to any penalty for failing to comply with a collection of information subject to the Paperwork Reduction Act

(PRA)that does not display a valid control number. Comments are requested concerning

(a)whether the proposed collection of information is necessary for the proper performance of the functions of the Commission, including whether the information shall have practical utility;

(b)the accuracy of the Commission's burden estimate;

(c)ways to enhance the quality, utility, and clarity of the information collected; and

(d)ways to minimize the burden of the collection of information on the respondents, including the use of automated collection techniques or other forms of information technology. DATES: Written comments should be submitted on or before January 12, 2007. If you anticipate that you will be submitting comments, but find it difficult to do so within the period of time allowed by this notice, you should advise the contact listed below as soon as possible. ADDRESSES: You may submit your Paperwork Reduction Act

(PRA)comments by e-mail or U.S. postal mail. To submit your comments by e-mail send them to *PRA@fcc.gov* . To submit your comments by U.S. mail, mark them to the attention of Cathy Williams, Federal Communications Commission, Room 1-C823, 445 12th Street, SW., Washington, DC 20554 and Allison E. Zaleski, Office of Management and Budget (OMB), Room 10236 NEOB, Washington, DC 20503,

(202)395-6466 or via the Internet at *Allison_E._Zaleski@omb.eop.gov* . FOR FURTHER INFORMATION CONTACT: For additional information about the information collection(s) send an e-mail to PRA@fcc.gov or contact Cathy Williams at

(202)418-2918. If you would like to obtain a copy of the information collection, you may do so by visiting the FCC PRA Web page at: *http://www.fcc.gov/omd/pra.* SUPPLEMENTARY INFORMATION: *OMB Control Number:* 3060-0349. *Title:* Sections 73.2080, 76.73, 76.75, 76.79, 76.1702, Equal Employment Opportunity (“EEO”) Policy. *Form Number:* Not applicable. *Type of Review:* Revision of a currently approved collection. *Respondents:* Business or other for-profit entities; not-for-profit institutions. *Number of Respondents:* 14,178. *Estimated Time per Response:* 42 hours. *Frequency of Response:* Recordkeeping requirement; Annual reporting requirement; Every five-year reporting requirement. *Obligation to Respond:* Required to obtain or retain benefits. *Total Annual Burden:* 595,476 hours. *Total Annual Cost:* None. *Privacy Impact Assessment:* No impact(s). *Nature and Extent of Confidentiality:* There is no need for confidentiality. *Needs and Uses:* 47 CFR 73.2080 provides that equal opportunity in employment shall be afforded by all broadcast stations to all qualified persons and no person shall be discriminated against in employment by such stations because of race, color, religion, national origin or sex. This section also requires that each broadcast station employment unit with 5 or more full-time employees shall establish, maintain and carry out a program to assure equal opportunity in every aspect of a broadcast station's policy and practice. Section 76.73 provides that equal opportunity in employment shall be afforded by all multichannel video program distributors (“MVPD”) to all qualified persons and no person shall be discriminated against in employment by such entities because of race, color, religion, national origin, age or sex. Section 76.75 requires that each MVPD employment unit shall establish, maintain and carry out a program to assure equal opportunity in every aspect of a cable entity's policy and practice. Section 76.79 requires that every MVPD employment unit maintain, for public inspection, a file containing copies of all annual employment reports and related documents. Section 76.1702 requires that every MVPD place certain information concerning its EEO program in the public inspection file. Federal Communications Commission. Marlene H. Dortch, Secretary. [FR Doc. E6-21000 Filed 12-12-06; 8:45 am] BILLING CODE 6712-01-P FEDERAL COMMUNICATIONS COMMISSION Notice of Public Information Collection(s) Being Submitted for Review to the Office of Management and Budget December 5, 2006. SUMMARY: The Federal Communications Commission, as part of its continuing effort to reduce paperwork burden invites the general public and other Federal agencies to take this opportunity to comment on the following information collection(s), as required by the Paperwork Reduction Act

(PRA)that does not display a valid control number. Comments are requested concerning

(a)whether the proposed collection of information is necessary for the proper performance of the functions of the Commission, including whether the information shall have practical utility;

(b)the accuracy of the Commission's burden estimate;

(c)ways to enhance the quality, utility, and clarity of the information collected; and

(202)395-6466, or via fax at

(202)418-0217 or via the Internet at *Leslie.Smith@fcc.gov* . SUPPLEMENTARY INFORMATION: *OMB Control Number:* 3060-0059. *Title:* Statement Regarding the Importation of Radio Frequency Devices Capable of Harmful Interference, FCC Form 740. *Form Number:* FCC 740. *Type of Review:* Extension of a currently approved collection. *Respondents:* Business or other for-profit entities. *Number of Respondents:* 5,000. *Estimated Time per Response:* 1-5 minutes. *Frequency of Response:* One time and on occasion reporting requirement; Third party disclosure. *Obligation To Respond:* Required to obtain or retain benefits. *Total Annual Burden:* 29,120 hours. *Total Annual Costs:* None. *Nature and Extent of Confidentiality:* There are no confidentiality issues. *Privacy Act Impact Assessment:* No impact(s). *Needs and Uses:* The FCC, working in conjunction with the U.S. Customs Service, is responsible for the regulation of both authorized radio services and devices that can cause interference. FCC Form 740 must be completed for each radio frequency device, which is imported into the United States, and is used to keep non-compliant devices from being distributed to the general public, thereby reducing the potential for harmful interference being caused to authorized communications. FCC Form 740 may be filed on paper or electronically via the FCC's Internet portal. Federal Communications Commission. Marlene H. Dortch, Secretary. [FR Doc. E6-21001 Filed 12-12-06; 8:45 am] BILLING CODE 6712-01-P FEDERAL COMMUNICATIONS COMMISSION Notice of Public Information Collection(s) Being Submitted for Review to the Office of Management and Budget December 7, 2006. SUMMARY: The Federal Communications Commission, as part of its continuing effort to reduce paperwork burden invites the general public and other Federal agencies to take this opportunity to comment on the following information collection(s), as required by the Paperwork Reduction Act

(PRA)that does not display a valid control number. Comments are requested concerning

(a)whether the proposed collection of information is necessary for the proper performance of the functions of the Commission, including whether the information shall have practical utility;

(b)the accuracy of the Commission's burden estimate;

(c)ways to enhance the quality, utility, and clarity of the information collected; and

(202)395-6466, or via fax at 202-395-5167 or via Internet at *Allison_E._Zaleski@eop.omb.gov* and to *Judith-B.Herman@fcc.gov* , Federal Communications Commission, Room 1-B441, 445 12th Street, SW., Washington, DC 20554 or an e-mail to *PRA@fcc.gov* . If you would like to obtain or view a copy of this information collection, you may do so by visiting the FCC PRA Web page at: *http://www.fcc.gov/omd/pra* . FOR FURTHER INFORMATION CONTACT: For additional information or copies of the information collection(s), contact Judith B. Herman at 202-418-0214 or via the Internet at *Judith-B.Herman@fcc.gov* . SUPPLEMENTARY INFORMATION: *OMB Control Number:* 3060-0855. *Title:* Telecommunications Reporting Worksheet, CC Docket No. 96-45. *Form Nos.:* FCC Forms 499-A and 499-Q. *Type of Review:* Revision of a currently approved collection. *Respondents:* Business or other for-profit and not-for-profit institutions. *Number of Respondents:* 5,625 respondents; 17,465 responses. *Estimated Time per Response:* 15 hours (average). *Frequency of Response:* On occasion, one-time, annual and quarterly reporting requirements, recordkeeping requirement and third party disclosure requirement. *Obligation to Respond:* Mandatory. *Total Annual Burden:* 263,230 hours. *Total Annual Cost:* N/A. *Privacy Act Impact Assessment:* N/A. *Nature and Extent of Confidentiality:* The Commission will allow respondents to certify that data contained in their submissions are privileged or confidential commercial or financial information and that disclosure of such information would likely cause substantial harm to the competitive position of the entity filing the Worksheet. If the Commission receives a request for or proposes to disclose the information, the respondent would be required to make the full showing pursuant to the Commission's rules for withholding from public inspection information submitted to the Commission. (See 47 CFR 0.459). *Needs and Uses:* The Commission will submit this information collection to OMB as a revision during this comment period to obtain the full three-year clearance from them. The Federal Communications Commission (Commission) requires telecommunications carriers and other providers of telecommunications to contribute to the Universal Service Fund

(USF)and other funds. Contribution revenue data, as well as other information, are reported by carriers on FCC Forms 499-A (annual) and 499-Q (quarterly). Accompanying these forms are instructions on how to report revenue. The revisions that are proposed for this information collection will provide clarifications to the 2007 FCC Forms 499-A and 499-Q, and instructions in order to improve the revenue reporting process for respondents. The revisions provide filers with additional information concerning, for example, the reporting of prepaid calling card revenue to reflect clarifications adopted in various Commission orders; the treatment of wireline broadband internet access service revenue as a result of the Commission's Wireline Broadband Internet Access Services Order; and the filing of revenues by VoIP toll providers to reflect the Commission's IP-in-the-Middle Order. The revisions also provide guidance to entities regarding filing of Form 499-A and 499-Q following the merger of two entities. The forms and instructions also provide additional information on the need for, and use of, e-mail addresses from the filing entities. Other proposed changes to the forms and instructions would help respondents better determine how to report subject revenues and generally seek to provide respondents with an efficient, less burdensome information collection. The revisions proposed will be minimal or have no effect on the burden associated with filing FCC Forms 499-A and 499-Q for respondents. The revisions proposed in this submission to OMB would go into effect January 31, 2007. In addition, the 2006 FCC forms and instructions which already reflect the changes to the contribution methodology adopted in the 2006 Interim Contribution Methodology Order should remain in effect until the revised forms become effective January 31, 2007 and should continue to be available thereafter for filers to use in amending prior submissions. On July 27, 2006, the Commission received emergency approval of the information collection requirements in which the Commission made minor editorial corrections of typographical errors or omissions as well as other minor changes to ensure consistency between the forms and the instructions. OMB approval for emergency requests are only granted for six months, thus this collection's OMB approval will expire on 1/31/07. The Commission is now submitting this collection under OMB's regular procedures in order to obtain the full three year clearance from them. Federal Communications Commission. Marlene H. Dortch, Secretary. [FR Doc. E6-21204 Filed 12-12-06; 8:45 am] BILLING CODE 6712-01-P FEDERAL MARITIME COMMISSION Notice of Agreements Filed The Commission hereby gives notice of the filing of the following agreements under the Shipping Act of 1984. Interested parties may submit comments on agreements to the Secretary, Federal Maritime Commission, Washington, DC 20573, within ten days of the date this notice appears in the **Federal Register** . Copies of agreements are available through the Commission's Office of Agreements (202-523-5793 or *tradeanalysis@fmc.gov* ). *Agreement No.:* 010071-033. *Title:* Cruise Lines International Association Agreement. *Parties:* American Cruise Lines, Inc.; Carnival Cruise Lines; Celebrity Cruises, Inc.; Costa Cruise Lines; Crystal Cruises; Cunard Line; Disney Cruise Line; Holland America Line; MSC Cruises; NCL America; Norwegian Coastal Voyage, Inc./Bergen Line Services; Norwegian Cruise Line; Oceania Cruises; Orient Lines; Princess Cruises; Regent Seven Seas Cruises; Royal Caribbean International; Seabourn Cruise Line; SeaDream Yacht Club; Silversea Cruises, Ltd.; and Windstar Cruises. *Filing Party:* Terry Dale, President; Cruise Lines International Association; 80 Broad Street; Suite 1800; New York, NY 10004. *Synopsis:* The amendment reflects changes to the Association arising from its consolidation with the International Council of Cruise Lines and CLIA's subsequent incorporation. The amendment also adds NCL America and SeaDream Yacht Club as parties. *Agreement No.:* 011574-017. *Title:* Pacific Islands Discussion Agreement. *Parties:* CMA CGM, SA; Compagnie Maritime Marfret, SA; Hamburg-Süd; Hapag-Lloyd AG; and Polynesia Line Ltd. *Filing Party:* Wayne R. Rohde, Esq.; Sher & Blackwell, LLP; 1850 M Street, NW.; Suite 900; Washington, DC 20036. *Synopsis:* The amendment removes Australia-New Zealand Direct Line as a party to the agreement. *Agreement No.:* 011947-003. *Title:* Grimaldi/Sallaum Space Charter Agreement. *Parties:* Grimaldi Compagnia di Navigazione and Sallaum Lines SAL. *Filing Party:* Wayne R. Rohde, Esq.; Sher & Blackwell LLP; 1850 M Street, NW.; Suite 900; Washington, DC 20036. *Synopsis:* The amendment expands the geographic scope of the agreement to cover all ports in West Africa in the Senegal to Angola range. *Agreement No.:* 201143-008. *Title:* West Coast MTO Agreement. *Parties:* APM Terminals Pacific, Ltd.; California United Terminals, Inc.; Eagle Marine Services, Ltd.; International Transportation Service, Inc.; Long Beach Container Terminal, Inc.; Seaside Transportation Service LLC; Trans Pacific Container Service Corporation; Total Terminals LLC; West Basin Container Terminal LLC; Yusen Terminals, Inc.; Pacific Maritime Services, L.L.C.; and SSA Terminal (Long Beach), LLC. *Filing Party:* David F. Smith, Esq.; Sher & Blackwell LLP; 1850 M Street, NW.; Suite 900; Washington, DC 20036. *Synopsis:* The amendment adds language and new Articles to the agreement to authorize the parties to discuss, agree upon and implement or assist in the implementation of measures to improve air quality in port areas and agree upon, test and implement security related measures, particularly those relating to transportation worker identification credentials. Dated: December 8, 2006. By Order of the Federal Maritime Commission. Bryant L. VanBrakle, Secretary. [FR Doc. E6-21179 Filed 12-12-06; 8:45 am] BILLING CODE 6730-01-P FEDERAL MARITIME COMMISSION Ocean Transportation Intermediary License Applicants Notice is hereby given that the following applicants have filed with the Federal Maritime Commission an application for license as a Non-Vessel-Operating Common Carrier and Ocean Freight Forwarder—Ocean Transportation Intermediary pursuant to section 19 of the Shipping Act of 1984 as amended (46 U.S.C. Chapter 409 and 46 CFR part 515). Persons knowing of any reason why the following applicants should not receive a license are requested to contact the Office of Transportation Intermediaries, Federal Maritime Commission, Washington, DC 20573. Non-Vessel-Operating Common Carrier Ocean Transportation Intermediary Applicants: Transmodal Logistics International Inc., 5520 Minoru Blvd., Suite 202, Richmond, British Columbia, Canada V6X 249. Officers: Sanjeev Bhalla, Vice President (Qualifying Individual), Dave B. Tangry, President. ILS Cargo Corp. dba Container Line, 7517-21 NW 52 Street, Miami, FL 33166. Officers: Placido Sanchez, President (Qualifying Individual), Rafael Mosquera, Vice President. Non-Vessel-Operating Common Carrier and Ocean Freight Forwarder Transportation Intermediary Applicants: Cedars Express International, Inc., 8415 Beckford Avenue, Northridge, CA 91324. Officers: Manal Fouad Guirguis, Vice President (Qualifying Individual), George N. Salloum, President. Ferrara International Worldwide Inc., 640 Dowd Avenue, Elizabeth, NJ 07201. Officers: Suzanne Simonetti, Vice President (Qualifying Individual), Nicholas Ferrara, President. Ocean Freight Forwarder—Ocean Transportation Intermediary Applicants: Mayfak International, LLC, 1231 NW 93 Ct., Doral, FL 33172. Officer: Mario Osorio, President (Qualifying Individual). International Logistics Solutions, Inc., 58 South Burty Road, Piedmont, SC 29673. Officers: Gavin Berkowitz, Vice President (Qualifying Individual), Chris Apple, President. Dated: December 8, 2006. Bryant L. VanBrakle, Secretary. [FR Doc. E6-21177 Filed 12-12-06; 8:45 am] BILLING CODE 6730-01-P FEDERAL MARITIME COMMISSION Ocean Transportation Intermediary Licenses Correction In the OTI Applicant Notice published in the **Federal Register** on November 1, 2006 (71 FR 64281) reference to the name of the Zenus

(USA)Logistics LLC is corrected to read: “Zeus

(USA)Logistics LLC”. Dated: December 8, 2006. Bryant L. VanBrakle, Secretary. [FR Doc. E6-21168 Filed 12-12-06; 8:45 am] BILLING CODE 6730-01-P FEDERAL RESERVE SYSTEM Change in Bank Control Notices; Acquisition of Shares of Bank or Bank Holding Companies The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. The factors that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices also will be available for inspection at the office of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments must be received not later than December 28, 2006. **A. Federal Reserve Bank of Kansas City** (Donna J. Ward, Assistant Vice President) 925 Grand Avenue, Kansas City, Missouri 64198-0001: *1. Raymond E. Wooldridge* , Dallas, Texas; to acquire voting shares of Reeves Bancshares, Inc., Gould, Oklahoma, and thereby indirectly acquire voting shares of Stockmans Bank, Altus, Oklahoma. Board of Governors of the Federal Reserve System, December 8, 2006. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E6-21149 Filed 12-12-06; 8:45 am] BILLING CODE 6210-01-S FEDERAL TRADE COMMISSION Charges For Certain Disclosures AGENCY: Federal Trade Commission. ACTION: Notice regarding charges for certain disclosures. SUMMARY: The Federal Trade Commission announces that the ceiling on allowable charges under Section 612(f) of the Fair Credit Reporting Act (“FCRA”) will remain unchanged at $10.00 for 2007. Under 1996 amendments to the FCRA, the Federal Trade Commission is required to increase the $8.00 amount referred to in paragraph (1)(A)(i) of Section 612(f) on January 1 of each year, based proportionally on changes in the Consumer Price Index (“CPI”), with fractional changes rounded to the nearest fifty cents. The CPI increased 25.88 percent between September 1997, the date the FCRA amendments took effect, and September 2006. This increase in the CPI and the requirement that any increase be rounded to the nearest fifty cents results in no change in the current maximum allowable charge of $10.00. DATES: *Effective Date:* January 1, 2007. ADDRESSES: Federal Trade Commission, Washington, DC 20580. FOR FURTHER INFORMATION CONTACT: Keith B. Anderson, Bureau of Economics, Federal Trade Commission, Washington, DC 20580, 202-326-3428. SUPPLEMENTARY INFORMATION: Section 612(f)(1)(A) of the Fair Credit Reporting Act, which became effective in 1997, provides that a consumer reporting agency may charge a consumer a reasonable amount for making a disclosure to the consumer pursuant to Section 609 of the Act. 1 The law states that, where a consumer reporting agency is permitted to impose a reasonable charge on a consumer for making a disclosure to the consumer pursuant to Section 609, the charge shall not exceed $8 and shall be indicated to the consumer before making the disclosure. Section 612(f)(2) states that the Federal Trade Commission (“the Commission”) shall increase the $8.00 maximum amount on January 1 of each year, based proportionally on changes in the Consumer Price Index, with fractional changes rounded to the nearest fifty cents. 1 This provision, originally Section 612(a), was added to the FCRA in September 1996 and became effective in September 1997. It was relabeled Section 612(f) by Section 211(a)(1) of the Fair and Accurate Credit Transactions Act of 2003 (“FACT Act”), Public Law 108-159, which was signed into law on December 4, 2003. Section 211(a)(2) of the Fair and Accurate Credit Transactions Act of 2003 (“FACT Act”) added a new Section 612(a) to the FCRA that gives consumers the right to request free annual disclosures once every 12 months. The maximum allowable charge established by this Notice does not apply to requests made under that provision. The charge will, however, apply when a consumer who orders a file disclosure has already received a free annual disclosure and does not otherwise qualify for an additional free disclosure. The Commission considers the $8 amount referred to in paragraph (1)(A)(i) of Section 612(f) to be the baseline for the effective ceiling on reasonable charges dating from the effective date of the amended FCRA, *i.e.* , September 30, 1997. Each year the Commission calculates the proportional increase in the Consumer Price Index (using the most general CPI, which is for all urban consumers, all items) from September 1997 to September of the current year. The Commission then determines what modification, if any, from the original base of $8 should be made effective on January 1 of the subsequent year, given the requirement that fractional changes be rounded to the nearest fifty cents. Between September 1997 and September 2006, the Consumer Price Index for all urban consumers and all items increased by 25.88 percent—from an index value of 161.2 in September 1997 to a value of 202.9 in September 2005. An increase of 25.88 percent in the $8.00 base figure would lead to a new figure of $10.07. However, because the statute directs that the resulting figure be rounded to the nearest $0.50, the allowable charge should be $10.00. The Commission therefore determines that the allowable charge for the year 2007 will remain unchanged at $10.00. By direction of the Commission. Donald S. Clark, Secretary. [FR Doc. E6-21196 Filed 12-12-06; 8:45 am] BILLING CODE 6750-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Request for Information (RFI): Improving Health and Accelerating Personalized Health Care Through Health Information Technology and Genomic Information in Population- and Community-based Health Care Delivery Systems; Extension of Comment Period AGENCY: Office of the Secretary, Department of Health and Human Services. ACTION: Notice. SUMMARY: On November 1, 2006, the U.S. Department of Health and Human Services

(HHS)issued a notice in the **Federal Register** (FR Doc. Vol 71, No. 211, pages 64282-64284) to request input from the public and private sectors on plans for developing and using resources involving health information technology and genetic and molecular medicine, with specific reference to incorporating these capacities in evidence-based clinical practice, health outcomes evaluations, and research. A 60 day comment period was established upon publication of that notice. The purpose of this notice is to inform all interested parties that the comment period originally identified in the November 1, 2006 **Federal Register** has been extended for thirty days, in order to maximize the opportunity for interested individuals and organizations to provide comments to HHS on this subject. DATES: The closing period for the comment period will now be February 5, 2007. ADDRESSES: Electronic responses are preferred and may be addressed to *PHCRFI@hhs.gov.* Written responses should be addressed to U.S. Department of Health and Human Services, Room 434E, 200 Independence Avenue SW., Washington, DC 20201, Attention: Personalized Health Care RFI. FOR FURTHER INFORMATION CONTACT: Dr. Gregory Downing, Personalized Health Care Initiative,

(202)260-1911. SUPPLEMENTARY INFORMATION: A copy of this RFI is available on the HHS Web site at *http://www.aspe.hhs.gov/PHC/rfi* . Please follow the instructions for submitting responses. Dated: December 6, 2006. John O. Agwunobi, Assistant Secretary for Health, Office of Public Health and Science. [FR Doc. E6-21146 Filed 12-12-06; 8:45 am] BILLING CODE 4150-28-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day-07-07AB] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention

(CDC)will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404-639-5960 and send comments to Seleda Perryman, CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail to *omb@cdc.gov.* Comments are invited on:

(a)Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility;

(b)the accuracy of the agency's estimate of the burden of the proposed collection of information;

(c)ways to enhance the quality, utility, and clarity of the information to be collected; and

(d)ways to minimize the burden of the collection of information on respondents, including through the Use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project Measuring the Psychological Impact on Communities Affected by Landmines—New—Coordinating Center for Environmental Health and Injury Prevention (CCEHIP), Centers for Disease Control and Prevention (CDC). Background and Brief Description The purpose of this project is to conduct an observational baseline survey that assesses the effectiveness of Humanitarian Mine Action (landmine and unexploded ordinance clearance, also known as demining) upon the economic, social and mental well being of impacted communities. This work will be conducted by the Harvard Humanitarian Initiative, a center of Harvard University, under a cooperative agreement with CDC. The general theory to be examined is that individuals and communities in these locations suffer when living in an area with landmines and unexploded ordinance

(UXO)since they cannot use all land resources and suffer the trauma of injured or killed family members. This research on the impact of demining is necessary because landmines and UXO continue to negatively impact civilian populations. For example, it has been estimated that each year landmines and unexploded ordinance lead to the injury and death of 24,000 persons worldwide, predominately civilians. At the same time, it is estimated that civilians account for 35% to 65% of war-related deaths and injuries. The use of landmines and UXO is ongoing, and therefore this issue merits continued attention. Up to this point, however, little if any of the international response to landmines has studied the economic, social, and mental impact upon a community. Instead the focus has been their physical impact in terms of numbers of injured and killed. There are not statistics nor is there research that can accurately capture these alternative measures of impact. There now exists an opportunity for further research that will benefit the general public as well as the organizations and governments working with persons impacted by landmines and UXO. The proposed work will allow CDC to continue its commitment to reduce the negative health impact posed by landmines and unexploded ordinance, both for U.S. and non-U.S.-based populations. Specific activities for this project include: a. Identify and incorporate public health principles into the planning of a pilot study for assessing the impact of landmine and unexploded ordinance

(UXO)abatement (also known as demining) on the economic, social and mental health of contaminated communities. This initial research in three or more locations will lay the groundwork for further study in additional sites around the world. b. Develop the survey instrument and design a study that will assess the economic, social and mental health consequences of living in areas where landmines and UXO are present and the impact if they are cleared. c. Collect and analyze data in order to draw conclusions and describe key findings that can be presented to the mine action community, which consists of United Nations (UN), governmental and non-governmental organizations

(NGOs)focused on reducing the negative impact of mines and unexploded ordinance. d. Develop materials and strategies for the wide dissemination of findings from the study. Organizations making up the mine action community will benefit from the ability to incorporate results (such as what practices alleviate negative social impacts on a community) of the research into their current practices. e. Identify and understand all critical aspects of the demining or abatement process, which includes the proper procedures and techniques for demining, the distinction between humanitarian and military demining, a thorough understanding of international standards for demining, and the ability to critically evaluate the quality of demining programs and their work. f. The work will be conducted in one country per year for a total of five years, depending upon available funding. The likely countries are: Angola, Bosnia, Colombia, Lebanon, and Nepal. There are no costs to respondents except their time to participate in the survey. *Annualized Burden Hours:* Respondents Number of respondents per year Number of responses/ respondent Avg. burden per response (in hrs.) Total annual burden (in hrs.) Persons Identified Annually in each Country 1580 1 1 1580 Dated: December 7, 2006. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E6-21192 Filed 12-12-06; 8:45 am] BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention: Teleconference In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention

(CDC)announces the aforementioned Advisory Committee meeting. *Time and Date:* 4 p.m.-5 p.m. Eastern Standard Time, December 14, 2006. *Place:* The conference call will originate at the Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333. Please see “Supplementary Information” for details on accessing the conference call. *Status:* Open to the public, limited only by the availability of telephone ports. *Purpose:* The committee will provide advice to the CDC Director on policy issues and broad strategies that will enable CDC, the Nation's prevention agency, to fulfill its mission of promoting health and quality of life by preventing and controlling disease, injury, and disability. *Matters To Be Discussed:* The committee will review and discuss recommendations submitted by the Health Disparities Subcommittee, ACD and the Ethics Subcommittee, ACD. Agenda items are subject to change as priorities dictate. *Supplementary Information:* This conference call is scheduled to begin at 4:00 p.m., Eastern Standard Time. To participate in the conference call, please dial 1-888-577-8993 and reference passcode “Public Health”. As provided under 41 CFR 102-3.150(b), the public health urgency of this agency business requires that the meeting be held prior to the first available date for publication of this notice in the **Federal Register** . *Contact Person For More Information:* Lynn Austin, PhD, Executive Secretary, Advisory Committee to the Director, CDC, 1600 Clifton Road, NE, M/S D-14, Atlanta, Georgia 30333. Telephone 404-639-7000. The Director, Management Analysis and Services Office, has been delegated the authority to sign **Federal Register** notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: December 7, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6-21270 Filed 12-12-06; 8:45 am] BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers For Medicare & Medicaid Services Privacy Act of 1974; Report of New System of Records AGENCY: Department of Health and Human Services (HHS), Centers for Medicare & Medicaid Services (CMS). ACTION: Notice of a new system of records. SUMMARY: In accordance with the requirements of the Privacy Act of 1974, CMS is proposing to establish a new system of records

(SOR)titled “Medicare Integrated Data Repository (IDR),” System No. 09-70-0571. In December 2003, Congress passed the Medicare Prescription Drug, Improvement, and Modernization Act of 2003

(MMA)(Pub. L. 108-173), that amends Title XVIII of the Social Security Act (the Act) by adding Part D, the voluntary prescription drug benefit program. The IDR will provide an organized structure for reaching the data through a consistent application of access policies, processes and procedures, common services, governance, and framework. The IDR will integrate and load data from various CMS systems consisting of Medicare Parts A, B, C, and D entitlement, enrollment and utilization data. It is proposed that the IDR will also contain demographic information on Medicaid beneficiaries, Medicare providers and physicians, and employer plans that are receiving a subsidy from CMS for providing creditable drug coverage to their retirees. It is through the integration of this data with other data (e.g., historic data, Part A and Part B data) that the IDR will have value for quality improvement, research on outcomes and effectiveness of drugs, post-market surveillance, and other analytic efforts. The primary purpose of this system is to establish an enterprise resource that will provide one integrated view of all CMS data to administer the Medicare and Medicaid programs. Information retrieved from this system of records will also be disclosed to:

(1)Support regulatory, reimbursement, and policy functions performed within the agency or by a contractor, consultant or CMS grantee;

(2)assist another Federal or state agency, agency of a state government, an agency established by state law, or its fiscal agent;

(3)support providers and suppliers of services for administration of Title XVIII;

(4)assist third parties where the contact is expected to have information relating to the individual's capacity to manage his or her own affairs;

(5)assist Medicare Advantage Plans and Part D Prescription Drug Plans;

(6)support Quality Improvement Organizations (QIO);

(7)assist other insurers for processing individual insurance claims;

(8)facilitate research on the quality and effectiveness of care provided, as well as payment related projects;

(9)support litigation involving the agency; and

(10)combat fraud, waste, and abuse in certain health benefits programs. We have provided background information about the new system in the SUPPLEMENTARY INFORMATION section below. Although the Privacy Act requires only that CMS provide an opportunity for interested persons to comment on the routine uses, CMS invites comments on all portions of this notice. See *Effective Dates* section for comment period. DATES: *Effective Date:* CMS filed a new SOR report with the Chair of the House Committee on Government Reform and Oversight, the Chair of the Senate Committee on Homeland Security & Governmental Affairs, and the Administrator, Office of Information and Regulatory Affairs, Office of Management and Budget

(OMB)on 11/28/2006. To ensure that all parties have adequate time in which to comment, the new system will become effective 30 days from the publication of the notice, or 40 days from the date it was submitted to OMB and the congress, whichever is later. We may defer implementation of this system or one or more of the routine use statements listed below if we receive comments that persuade us to defer implementation. ADDRESSES: The public should address comments to the CMS Privacy Officer, Division of Privacy Compliance, Enterprise Architecture and Strategy Group, Office of Information Services, CMS, Mailstop N2-04-27, 7500 Security Boulevard, Baltimore, Maryland 21244-1850. Comments received will be available for review at this location, by appointment, during regular business hours, Monday through Friday from 9 a.m.-3 p.m., eastern daylight time. FOR FURTHER INFORMATION CONTACT: Robyn Thomas, Director, Division of Business Analysis & Operations, Enterprise Databases Group, Office of Information Services, CMS, Room N1-14-08, 7500 Security Boulevard, Baltimore, Maryland 21244-1850. The telephone number is 410-786-6063 or contact *robyn.thomas@cms.hhs.gov* . SUPPLEMENTARY INFORMATION: In December 2003, Congress passed the Medicare Prescription Drug, Improvement, and Modernization Act, amending the Act by adding Part D under Title XVIII. Under the new Medicare benefit, prescription drug coverage is available to everyone with Medicare, regardless of income or health status. CMS maintains numerous systems housing Medicare beneficiary Parts A, B, C and D entitlement, enrollment, and utilization information. Additionally, CMS maintains data on physicians, providers, employer plans, Medicaid recipients and Medicare secondary payers. Implementation of provisions of the MMA requires that CMS develop and maintain databases and systems to manage the enrollment of individuals in the drug benefit or subsidy assistance programs, pay prescription drug plans, evaluate the quality of the new prescription drug benefit, support drug research, provide better access to data, and provide opportunities for other government and research organizations to improve healthcare for the public. In order to more efficiently and effectively carry out the requirements of CMS's various program areas, data must be available to meet regulatory requirements and support research. Better access to data from all CMS healthcare programs will provide opportunities for other government and research organizations to use this same source data in their efforts to improve healthcare for the public. There are a large number of data sources, extraction tools, and access mechanisms. Users of the data often experience inconsistent, untimely, or duplicated information. The IDR will be an enterprise resource that will provide one integrated view of the data to all of CMS and its partners providing a single authoritative source of information and providing quality and timely data. Additionally, the IDR will contain protections that will maintain the privacy of beneficiaries and providers. Data will most frequently be retrieved by health insurance claim account number, provider or physician identification number, State of residence, or date of service. Such protections will consist of, but are not limited to, identity management, authentication, encrypted identifiers, governance roles, and personally identifiable and non-personally identifiable data stores. The data collected and maintained in this system are retrieved from the following databases: Medicare Drug Data Processing System, System No. 09-70-0553 (70 FR 58436 (October 6, 2005)); Medicare Beneficiary Database, System No. 09-70-0536 (71 FR 11425 (March 7, 2006)); Medicare Advantage Prescription Drug System, System No. 09-70-4001 (70 FR 60530 (October 18, 2005)); Medicaid Statistical Information System, System No. 09-70-0541 (71 FR 65527 (November 8, 2006)); Retiree Drug Subsidy Program, System No. 09-70-0550 (70 FR 41035 (July 15, 2005)); Common Working File, System No. 09-70-0526 (71 FR 64955 (November 6, 2006)); National Claims History, System No. 09-70-0005 (67 FR 57015 (September 6, 2002)); Enrollment Database, System No. 09-70-0502 (67 FR 3203 (January 23, 2002)); Multi-Carrier Claims System (formerly known as the Carrier Medicare Claims Record), System No. 09-70-0501 (71 FR 64968 (November 6, 2006)); Fiscal Intermediary Shared System (formerly known as the Intermediary Medicare Claims Record), System No. 09-70-0503 (71 FR 64961 (November 6, 2006)); Unique Physician/Provider Identification Number, System No. 09-70-0525, (69 FR 75316 (December 16, 2004)); Medicare Supplier Identification File, System No. 09-70-0530 (71 FR 65527 (November 8, 2006). I. Description of the Proposed System of Records A. Statutory and Regulatory Basis for System Authority for the collection of data maintained in this system is given under section 226, 226A, 1811, 1818, 1818A, 1831, 1833(a)(1)(A), 1836, 1837, 1838, 1843, 1866, 1874a, 1875, 1876, 1881, and 1902(a)(6) of the Social Security Act (the Act). The following are the corresponding sections from Title 42 of the United States Code (U.S.C.): 426, 426-1, 1395c, 1395i-2, 1395i-2a, 1395j, 1395l(a)(1)(A), 1395o, 1395p, 1395q, 1395v, 1395cc, 1395kk-l, 1395ll, 1395mm, 1395rr, 1396a(a)(6), and section 101 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003

(MMA)(Pub. L. 108-173), which established the Medicare Part D program. B. Collection and Maintenance of Data in the System This system will maintain information on Medicare beneficiaries Parts A, B, C, and D and physicians, providers, employer plans, Medicaid recipients and Medicare secondary payers. Information maintained in the system include, but are not limited to: Standard data for identification such as health insurance claim number, social security number, gender, race/ethnicity, date of birth, geographic location, Medicare enrollment and entitlement information, MSP data necessary for appropriate Medicare claim payment, hospice election, MA plan elections and enrollment, End Stage Renal Disease

(ESRD)entitlement, historic and current listing of residences, and Medicare eligibility and Managed Care institutional status. II. Agency Policies, Procedures, and Restrictions on The Routine Use A. The Privacy Act permits us to disclose information without an individual's consent if the information is to be used for a purpose that is compatible with the purpose(s) for which the information was collected. Any such disclosure of data is known as a “routine use.” The government will only release IDR information that can be associated with an individual as provided for under “Section III. Proposed Routine Use Disclosures of Data in the System.” Both identifiable and non-identifiable data may be disclosed under a routine use. We will only disclose the minimum personal data necessary to achieve the purpose of IDR. CMS has the following policies and procedures concerning disclosures of information that will be maintained in the system. In general, disclosure of information from the system will be approved only for the minimum information necessary to accomplish the purpose of the disclosure and only after CMS: 1. Determines that the use or disclosure is consistent with the reason that the data is being collected, *e.g.* , to assist in a variety of health care initiatives with other entities related to the evaluation and study of the operation and effectiveness of the Medicare program. 2. *Determines that:* a. The purpose for which the disclosure is to be made can only be accomplished if the record is provided in individually identifiable form; b. The purpose for which the disclosure is to be made is of sufficient importance to warrant the effect and/or risk on the privacy of the individual that additional exposure of the record might bring; and c. There is a strong probability that the proposed use of the data would in fact accomplish the stated purpose(s). 3. *Requires the information recipient to:* a. Establish administrative, technical, and physical safeguards to prevent unauthorized use of disclosure of the record; b. Remove or destroy at the earliest time all individually-identifiable information; and c. Agree to not use or disclose the information for any purpose other than the stated purpose under which the information was disclosed. 4. Determines that the data are valid and reliable. III. Proposed Routine Use Disclosures of Data in the System A. The Privacy Act allows us to disclose information without an individual's consent if the information is to be used for a purpose that is compatible with the purpose(s) for which the information was collected. Any such compatible use of data is known as a “routine use.” The proposed routine uses in this system meet the compatibility requirement of the Privacy Act. We are proposing to establish the following routine use disclosures of information maintained in the system: 1. To support agency contractors, consultants or grantees who have been engaged by the agency to assist in the performance of a service related to this system and who need to have access to the records in order to perform the activity. We contemplate disclosing information under this routine use only in situations in which CMS may enter into a contractual or similar agreement with a third party to assist in accomplishing CMS functions relating to purposes for this system. CMS occasionally contracts out certain of its functions when doing so would contribute to effective and efficient operations. CMS must be able to give a contractor, consultant or grantee whatever information is necessary for the contractors, consultants or grantees to fulfill its duties. In these situations, safeguards are provided in the contract prohibiting the contractor, consultant or grantee from using or disclosing the information for any purpose other than that described in the contract and requires the contractor, consultant or grantee to return or destroy all information at the completion of the contract. 2. *To assist another Federal or state agency, agency of a state government, an agency established by state law, or its fiscal agent to:* a. Contribute to the accuracy of CMS' proper payment of Medicare benefits, b. Enable such agency to administer a Federal health benefits program, or as necessary to enable such agency to fulfill a requirement of a Federal statute or regulation that implements a health benefits program funded in whole or in part with Federal funds, and/or c. Assist Federal/state Medicaid programs within the state. Other Federal or state agencies in their administration of a Federal health program may require IDR information in order to support evaluations and monitoring of Medicare claims information of beneficiaries, including proper reimbursement for services provided. The Internal Revenue Service may require IDR data for the application of tax penalties against employers and employee organizations that contribute to Employer Group Health Plans or Large Group Health Plans that are not in compliance with 42 U.S.C. 1395y(b). In addition, other state agencies in their administration of a Federal health program may require IDR information for the purpose of determining, evaluating and/or assessing cost effectiveness, and/or the quality of health care services provided in the state. The Railroad Retirement Board requires IDR information to administer provisions of the Railroad Retirement Act and Social Security Act relating to railroad employment and/or the administration of the Medicare program. The Social Security Administration requires IDR data to enable them to assist in the implementation and maintenance of the Medicare program. Disclosure under this routine use shall be used by state Medicaid agencies pursuant to agreements with HHS for determining Medicaid and Medicare eligibility, for quality control studies, for determining eligibility of recipients of assistance under Titles IV, XVIII, and XIX of the Act, and for the administration of the Medicaid program. Data will be released to the state only on those individuals who are patients under the services of a Medicaid program within the state who are residents of that state. 3. To support providers and suppliers of services directly or through fiscal intermediaries or carriers for the administration of Title XVIII of the Act. Providers and suppliers of services require IDR information in order to establish the validity of evidence or to verify the accuracy of information presented by the individual, as it concerns the individual's entitlement to benefits under the Medicare program, including proper reimbursement for services provided. 4. To assist third party contact in situations where the party to be contacted has, or is expected to have information relating to the individual's capacity to manage his or her affairs or to his or her eligibility for, or an entitlement to, benefits under the Medicare program and; a. The individual is unable to provide the information being sought (an individual is considered to be unable to provide certain types of information when any of the following conditions exists: The individual is confined to a mental institution, a court of competent jurisdiction has appointed a guardian to manage the affairs of that individual, a court of competent jurisdiction has declared the individual to be mentally incompetent, or the individual's attending physician has certified that the individual is not sufficiently mentally competent to manage his or her own affairs or to provide the information being sought, the individual cannot read or write, cannot afford the cost of obtaining the information, a language barrier exist, or the custodian of the information will not, as a matter of policy, provide it to the individual), or b. The data are needed to establish the validity of evidence or to verify the accuracy of information presented by the individual, and it concerns one or more of the following: The individual's entitlement to benefits under the Medicare program, the amount of reimbursement, and in cases in which the evidence is being reviewed as a result of suspected fraud, waste, and abuse, program integrity, quality appraisal, or evaluation and measurement of activities. Third parties contacts require IDR information in order to provide support for the individual's entitlement to benefits under the Medicare program; to establish the validity of evidence or to verify the accuracy of information presented by the individual, and assist in the monitoring of Medicare claims information of beneficiaries, including proper reimbursement of services provided. 5. To assist Medicare Advantage Plans, Part D Prescription Drug Plans and their Prescription Drug Event submitters, providing protection against medical expenses of their enrollees without the beneficiary's authorization, and having knowledge of the occurrence of any event affecting

(a)an individual's right to any such benefit or payment, or

(b)the initial right to any such benefit or payment, for the purpose of coordination of benefits with the Medicare program and implementation of the Medicare Secondary Payer provision at 42 U.S.C. 1395y (b). Information to be disclosed shall be limited to Medicare entitlement, enrollment and utilization data necessary to perform that specific function. In order to receive the information, they must agree to: a. Certify that the individual about whom the information is being provided is one of its insured or employees, or is insured and/or employed by another entity for whom they serve as a Third Party Administrator; b. Utilize the information solely for the purpose of processing the individual's enrollment or insurance claim; and c. Safeguard the confidentiality of the data and prevent unauthorized access. Other insurers may require IDR information in order to support evaluations and monitoring of Medicare claims information of beneficiaries, including proper reimbursement for services provided. 6. To support Quality Improvement Organizations

(QIO)in connection with review of claims, or in connection with studies or other review activities conducted pursuant to Part B of Title XI of the Act, and in performing affirmative outreach activities to individuals for the purpose of establishing and maintaining their entitlement to Medicare benefits or health insurance plans. As established by the Part D Program, QIOs will conduct reviews of prescription drug events data, or in connection with studies or other review activities conducted pursuant to Part D of Title XVIII of the Act. QIOs will work to implement quality improvement programs, provide consultation to CMS, MA-PD, PDPs, and state agencies, to assist CMS in prescription drug event assessments, and prepare summary information for release to CMS. QIOs will work to implement quality improvement programs, provide consultation to CMS, its contractors, and to state agencies. QIOs will assist state agencies in related monitoring and enforcement efforts, assist CMS and intermediaries in program integrity assessment, and prepare summary information for release to CMS. 7. To assist other insurers, underwriters, third party administrators (TPAs), self-insurers, group health plans, employers, health maintenance organizations, health and welfare benefit funds, Federal agencies, a state or local government or political subdivision of either (when the organization has assumed the role of an insurer, underwriter, or third party administrator, or in the case of a state that assumes the liabilities of an insolvent insurers pool or fund), multiple-employers trusts, no-fault medical, automobile insurers, workers' compensation carriers plans, liability insurers, and other groups providing protection against medical expenses who are primary payers to Medicare in accordance with 42 U.S.C. 1395y(b), or any entity having knowledge of the occurrence of any event affecting; a. An individual's right to any such benefit or payment, or b. The initial or continued right to any such benefit or payment (for example, a State Medicaid Agency, State Workers' Compensation Board, or Department of Motor Vehicles) for the purpose of coordination of benefits with the Medicare program and implementation of the MSP provisions at 42 U.S.C. 1395y(b). The information CMS may disclose will be: • Beneficiary Name • Beneficiary Address • Beneficiary Health Insurance Claim Number • Beneficiary Social Security Number • Beneficiary Gender • Beneficiary Date of Birth • Amount of Medicare Conditional Payment • Provider Name and Number • Physician Name and Number • Supplier Name and Number • Dates of Service • Nature of Service • Diagnosis To administer the MSP provision at 42 U.S.C. 1395y(b)(2), (3), and

(4)more effectively, CMS would receive (to the extent that it is available) and may disclose the following types of information from insurers, underwriters, third party administrator, self-insurers, etc.: • Subscriber Name and Address • Subscriber Date of Birth • Subscriber Social Security number • Dependent Name • Dependent Date of Birth • Dependent Social Security Number • Dependent Relationship to Subscriber • Insurer/Underwriter/TPA Name and Address • Insurer/Underwriter/TPA Group Number • Insurer/Underwriter/Group Name • Prescription Drug Coverage • Policy Number • Effective Date of Coverage • Employer Name, Employer Identification Number

(EIN)and Address • Employment Status • Amounts of Payment To administer the MSP provision at 42 U.S.C. 1395y(b)(1) more effectively for entities such as Workers' Compensation carriers or boards, liability insurers, no-fault and automobile medical policies or plans, CMS would receive (to the extent that it is available) and may disclose the following information: • Beneficiary's Name and Address • Beneficiary's Date of Birth • Beneficiary's Social Security number • Name of Insured • Insurer Name and Address • Type of coverage; automobile medical, no-fault, liability payment, or workers' compensation settlement • Insured's Policy Number • Effective Date of Coverage • Date of accident, injury or illness • Amount of payment under liability, no-fault, or automobile medical policies, plans, and workers' compensation settlements • Employer Name and Address (Workers' Compensation Only) • Name of insured could be the driver of the car, a business, the beneficiary (i.e., the name of the individual or entity which carries the insurance policy or plan) In order to receive this information the entity must agree to the following conditions; a. To utilize the information solely for the purpose of coordination of benefits with the Medicare program and other third party payer in accordance with Title 42 U.S.C. 1395y(b); b. To safeguard the confidentiality of the data and to prevent unauthorized access to it; and, c. To prohibit the use of beneficiary-specific data for the purposes other than for the coordination of benefits among third party payers and the Medicare program. This agreement would allow the entities to use the information to determine cases where they or other third party payers have primary responsibility for payment. Examples of prohibited uses would include but are not limited to: Creation of a mailing list, sale or transfer of data. To administer the MSP provisions more effectively, CMS may receive or disclose the following types of information from or to entities including insurers, underwriters, TPAs, and self-insured plans, concerning potentially affected individuals: • Subscriber HICN • Dependent Name • Funding arrangements of employer group health plans, for example, contributory or non-contributory plan, self-insured, re-insured, HMO, TPA insurance • Claims payment information, for example, the amount paid, the date of payment, the name of the insurers or payer • Dates of employment including termination date, if appropriate • Number of full and/or part-time employees in the current and preceding calendar years • Employment status of subscriber, for example, full or part time or self-employed Other insurers, HMO, and Health Care Prepayment Plans may require IDR information in order to support evaluations and monitoring of Medicare claims information of beneficiaries, including proper reimbursement for services provided. 1860D-23 and 1860D-24 of the Act require that the Secretary establish requirements for prescription drug plans (Part D plans) to ensure the effective coordination between a Part D plan and a State Pharmaceutical Assistance Program (SPAP), as well as other payers of prescription drug benefits, including enrollment file sharing. CMS, using its coordination of benefits contractor, allows this to happen by having payers that will be secondary to Part D submit their enrollment data in exchange for Part D enrollment data. The data shared is mainly enrollment information (date of enrollment into Part D, what Part D plan they are enrolled with). SPAPs, but not other payers, will also receive data indicating whether the beneficiary qualifies for a low-income subsidy to pay for drug costs. 8. To assist an individual or organization for a research project or in support of an evaluation project related to the prevention of disease or disability, the restoration or maintenance of health, or payment related projects. The IDR data will provide for research or in support of evaluation projects, a broader, longitudinal, national perspective of the status of Medicare beneficiaries. CMS anticipates that many researchers will have legitimate requests to use this data in projects that could ultimately improve the care provided to Medicare beneficiaries and the policy that governs the care. 9. *To support the Department of Justice (DOJ), court or adjudicatory body when:* a. The agency or any component thereof, or b. Any employee of the agency in his or her official capacity, or c. Any employee of the agency in his or her individual capacity where the DOJ has agreed to represent the employee, or d. The United States Government, is a party to litigation or has an interest in such litigation, and by careful review, CMS determines that the records are both relevant and necessary to the litigation and that the use of such records by the DOJ, court or adjudicatory body is compatible with the purpose for which the agency collected the records. Whenever CMS is involved in litigation, and occasionally when another party is involved in litigation and CMS' policies or operations could be affected by the outcome of the litigation, CMS would be able to disclose information to the DOJ, court or adjudicatory body involved. 10. To support a CMS contractor (including, but not necessarily limited to fiscal intermediaries and carriers) that assists in the administration of a CMS-administered health benefits program, or to a grantee of a CMS-administered grant program, when disclosure is deemed reasonably necessary by CMS to prevent, deter, discover, detect, investigate, examine, prosecute, sue with respect to, defend against, correct, remedy, or otherwise combat fraud, waste, or abuse in such program. We contemplate disclosing information under this routine use only in situations in which CMS may enter into a contractual relationship or grant with a third party to assist in accomplishing CMS functions relating to the purpose of combating fraud, waste, and abuse. CMS occasionally contracts out certain of its functions and makes grants when doing so would contribute to effective and efficient operations. CMS must be able to give a contractor or grantee whatever information is necessary for the contractor or grantee to fulfill its duties. In these situations, safeguards are provided in the contract prohibiting the contractor or grantee from using or disclosing the information for any purpose other than that described in the contract and requiring the contractor or grantee to return or destroy all information. 11. To support another Federal agency or to an instrumentality of any governmental jurisdiction within or under the control of the United States (including any State or local governmental agency), that administers, or that has the authority to investigate potential fraud, waste, or abuse in, a health benefits program funded in whole or in part by Federal funds, when disclosure is deemed reasonably necessary by CMS to prevent, deter, discover, detect, investigate, examine, prosecute, sue with respect to, defend against, correct, remedy, or otherwise combat fraud, waste, or abuse in such programs. Other agencies may require IDR information for the purpose of combating fraud, waste, and abuse in such Federally-funded programs. B. Additional Provisions Affecting Routine Use Disclosures To the extent this system contains Protected Health Information

(PHI)as defined by HHS regulation “Standards for Privacy of Individually Identifiable Health Information” (45 CFR Parts 160 and 164, Subparts A and E) 65 FR 82462 (12-28-00). Disclosures of such PHI that are otherwise authorized by these routine uses may only be made if, and as, permitted or required by the “Standards for Privacy of Individually Identifiable Health Information.” (See 45 CFR 164.512(a)(1)). In addition, our policy will be to prohibit release even of data not directly identifiable, except pursuant to one of the routine uses or if required by law, if we determine there is a possibility that an individual can be identified through implicit deduction based on small cell sizes (instances where the patient population is so small that individuals could, because of the small size, use this information to deduce the identity of the beneficiary). III. Safeguards CMS has safeguards in place for authorized users and monitors such users to ensure against unauthorized use. Personnel having access to the system have been trained in the Privacy Act and information security requirements. Employees who maintain records in this system are instructed not to release data until the intended recipient agrees to implement appropriate management, operational and technical safeguards sufficient to protect the confidentiality, integrity and availability of the information and information systems and to prevent unauthorized access. This system will conform to all applicable Federal laws and regulations and Federal, HHS, and CMS policies and standards as they relate to information security and data privacy. These laws and regulations may apply but are not limited to: The Privacy Act of 1974; the Federal Information Security Management Act of 2002; the Computer Fraud and Abuse Act of 1986; the Health Insurance Portability and Accountability Act of 1996; the E-Government Act of 2002, the Clinger-Cohen Act of 1996; the Medicare Modernization Act of 2003, and the corresponding implementing regulations. OMB Circular A-130, Management of Federal Resources, Appendix III, Security of Federal Automated Information Resources also applies. Federal, HHS, and CMS policies and standards include but are not limited to: All pertinent National Institute of Standards and Technology publications; the HHS Information Systems Program Handbook and the CMS Information Security Handbook. IV. Effects of the System of Records on Individual Rights CMS proposes to establish this system in accordance with the principles and requirements of the Privacy Act and will collect, use, and disseminate information only as prescribed therein. Data in this system will be subject to the authorized releases in accordance with the routine uses identified in this system of records. CMS will take precautionary measures to minimize the risks of unauthorized access to the records and the potential harm to individual privacy or other personal or property rights of patients whose data are maintained in the system. CMS will collect only that information necessary to perform the system's functions. In addition, CMS will make disclosure from the proposed system only with consent of the subject individual, or his/her legal representative, or in accordance with an applicable exception provision of the Privacy Act. CMS, therefore, does not anticipate an unfavorable effect on individual privacy as a result of information relating to individuals. Dated: November 24, 2006. John R. Dyer, Chief Operating Officer, Centers for Medicare & Medicaid Services. SYSTEM NO. 09-70-0571 SYSTEM NAME: “Medicare Integrated Data Repository (IDR), HHS/CMS/OIS” SECURITY CLASSIFICATION: Level Three Privacy Act Sensitive Data SYSTEM LOCATION: The Centers for Medicare & Medicaid Services

(CMS)Data Center, 7500 Security Boulevard, North Building, First Floor, Baltimore, Maryland 21244-1850. CATEGORIES OF INDIVIDUALS COVERED BY THE SYSTEM: This system maintains information on individuals age 65 or over who have been, or currently are, entitled to health insurance (Medicare) benefits under Title XVIII of the Social Security Act (the Act) or under provisions of the Railroad Retirement Act; individuals under age 65 who have been, or currently are, entitled to such benefits on the basis of having been entitled for not less than 24 months to disability benefits under Title II of the Act or under the Railroad Retirement Act; individuals who have been, or currently are, entitled to such benefits because they have End-Stage Renal Disease (ESRD); individuals age 64 and 8 months or over who are likely to become entitled to health insurance (Medicare) benefits upon attaining age 65, and individuals under age 65 who have at least 21 months of disability benefits who are likely to become entitled to Medicare upon the 25th month or entitlement to such benefits and those populations that are dually eligible for both Medicare and Medicaid (Title XIX of the Act). Additionally, this system will maintain information on Medicare beneficiaries Parts A, B, C, and D and physicians, providers, employer plans, Medicaid recipients and Medicare secondary payers. CATEGORIES OF RECORDS IN THE SYSTEM: Information maintained in the system include, but are not limited to: standard data for identification such as health insurance claim number, social security number, gender, race/ethnicity, date of birth, geographic location, Medicare enrollment and entitlement information, MSP data necessary for appropriate Medicare claim payment, hospice election, MA plan elections and enrollment, End Stage Renal Disease

(ESRD)entitlement, historic and current listing of residences, and Medicare eligibility and Managed Care institutional status. Additionally, this system will maintain identifying information on physicians, providers, employer plans, Medicaid recipients and Medicare secondary payers. AUTHORITY FOR MAINTENANCE OF THE SYSTEM: Authority for the collection of data maintained in this system is given under §§ 226, 226A, 1811, 1818, 1818A, 1831, 1833(a)(1)(A), 1836, 1837, 1838, 1843, 1866, 1874a, 1875, 1876, 1881, and 1902(a)(6) of the Social Security Act (the Act). The following are the corresponding sections from Title 42 of the United States Code (U.S.C.): 426, 426-1, 1395c, 1395i-2, 1395i-2a, 1395j, 1395l(a)(1)(A), 1395o, 1395p, 1395q, 1395v, 1395cc, 1395kk-l, 1395ll, 1395mm, 1395rr, 1396a(a)(6), and § 101 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003

(MMA)(Pub. L. 108-173), which established the Medicare Part D program. PURPOSE(S) OF THE SYSTEM: The primary purpose of this system is to establish an enterprise resource that will provide one integrated view of all CMS data to administer the Medicare and Medicaid programs. Information retrieved from this system of records will also be disclosed to:

(1)Support regulatory, reimbursement, and policy functions performed within the agency or by a contractor, consultant or CMS grantee;

(2)assist another Federal or state agency, agency of a state government, an agency established by state law, or its fiscal agent;

(3)support providers and suppliers of services for administration of Title XVIII;

(4)assist third parties where the contact is expected to have information relating to the individual's capacity to manage his or her own affairs;

(5)assist Medicare Advantage Plans and Part D Prescription Drug Plans;

(6)support Quality Improvement Organizations (QIO);

(7)assist other insurers for processing individual insurance claims;

(8)facilitate research on the quality and effectiveness of care provided, as well as payment related projects;

(9)support litigation involving the agency; and

(10)combat fraud, waste, and abuse in certain health benefits programs. ROUTINE USES OF RECORDS MAINTAINED IN THE SYSTEM, INCLUDING CATEGORIES OR USERS AND THE PURPOSES OF SUCH USES: A. The Privacy Act allows us to disclose information without an individual's consent if the information is to be used for a purpose that is compatible with the purpose(s) for which the information was collected. Any such compatible use of data is known as a “routine use.” The proposed routine uses in this system meet the compatibility requirement of the Privacy Act. We are proposing to establish the following routine use disclosures of information maintained in the system: 1. To support agency contractors, consultants or grantees who have been engaged by the agency to assist in the performance of a service related to this system and who need to have access to the records in order to perform the activity. 2. To assist another Federal or state agency, agency of a state government, an agency established by state law, or its fiscal agent to: a. Contribute to the accuracy of CMS' proper payment of Medicare benefits, b. Enable such agency to administer a Federal health benefits program, or as necessary to enable such agency to fulfill a requirement of a Federal statute or regulation that implements a health benefits program funded in whole or in part with Federal funds, and/or c. Assist Federal/state Medicaid programs within the state. 3. To support providers and suppliers of services directly or through fiscal intermediaries or carriers for the administration of Title XVIII of the Act. 4. To assist third party contact in situations where the party to be contacted has, or is expected to have information relating to the individual's capacity to manage his or her affairs or to his or her eligibility for, or an entitlement to, benefits under the Medicare program; and a. The individual is unable to provide the information being sought (an individual is considered to be unable to provide certain types of information when any of the following conditions exists: The individual is confined to a mental institution, a court of competent jurisdiction has appointed a guardian to manage the affairs of that individual, a court of competent jurisdiction has declared the individual to be mentally incompetent, or the individual's attending physician has certified that the individual is not sufficiently mentally competent to manage his or her own affairs or to provide the information being sought, the individual cannot read or write, cannot afford the cost of obtaining the information, a language barrier exists, or the custodian of the information will not, as a matter of policy, provide it to the individual), or b. The data are needed to establish the validity of evidence or to verify the accuracy of information presented by the individual, and it concerns one or more of the following: the individual's entitlement to benefits under the Medicare program, the amount of reimbursement, and in cases in which the evidence is being reviewed as a result of suspected fraud, waste, and abuse, program integrity, quality appraisal, or evaluation and measurement of activities. 5. To assist Medicare Advantage Plans, Part D Prescription Drug Plans and their Prescription Drug Event submitters, providing protection against medical expenses of their enrollees without the beneficiary's authorization, and having knowledge of the occurrence of any event affecting

(a)an individual's right to any such benefit or payment, or

(b)the initial right to any such benefit or payment, for the purpose of coordination of benefits with the Medicare program and implementation of the Medicare Secondary Payer provision at 42 U.S.C. 1395y(b). Information to be disclosed shall be limited to Medicare entitlement, enrollment and utilization data necessary to perform that specific function. In order to receive the information, they must agree to: a. Certify that the individual about whom the information is being provided is one of its insured or employees, or is insured and/or employed by another entity for whom they serve as a Third Party Administrator; b. Utilize the information solely for the purpose of processing the individual's enrollment or insurance claim; and c. Safeguard the confidentiality of the data and prevent unauthorized access. 6. To support Quality Improvement Organizations

(QIO)in connection with review of claims, or in connection with studies or other review activities conducted pursuant to Part B of Title XI of the Act, and in performing affirmative outreach activities to individuals for the purpose of establishing and maintaining their entitlement to Medicare benefits or health insurance plans. As established by the Part D Program, QIOs will conduct reviews of prescription drug events data, or in connection with studies or other review activities conducted pursuant to Part D of Title XVIII of the Act. 7. To assist other insurers, underwriters, third party administrators (TPAs), self-insurers, group health plans, employers, health maintenance organizations, health and welfare benefit funds, Federal agencies, a state or local government or political subdivision of either (when the organization has assumed the role of an insurer, underwriter, or third party administrator, or in the case of a state that assumes the liabilities of an insolvent insurers pool or fund), multiple-employers trusts, no-fault medical, automobile insurers, workers' compensation carriers plans, liability insurers, and other groups providing protection against medical expenses who are primary payers to Medicare in accordance with 42 U.S.C. 1395y(b), or any entity having knowledge of the occurrence of any event affecting; a. An individual's right to any such benefit or payment, or b. The initial or continued right to any such benefit or payment (for example, a State Medicaid Agency, State Workers' Compensation Board, or Department of Motor Vehicles) for the purpose of coordination of benefits with the Medicare program and implementation of the MSP provisions at 42 U.S.C. 1395y(b). The information CMS may disclose will be: • Beneficiary Name • Beneficiary Address • Beneficiary Health Insurance Claim Number • Beneficiary Social Security Number • Beneficiary Gender • Beneficiary Date of Birth • Amount of Medicare Conditional Payment • Provider Name and Number • Physician Name and Number • Supplier Name and Number • Dates of Service • Nature of Service • Diagnosis To administer the MSP provision at 42 U.S.C. 1395y(b)(2), (3), and

(PHI)as defined by HHS regulation “Standards for Privacy of Individually Identifiable Health Information” (45 CFR Parts 160 and 164, Subparts A and E) 65 FR 82462 (12-28-00). Disclosures of such PHI that are otherwise authorized by these routine uses may only be made if, and as, permitted or required by the “Standards for Privacy of Individually Identifiable Health Information.” (See 45 CFR 164.512(a)(1)). In addition, our policy will be to prohibit release even of data not directly identifiable, except pursuant to one of the routine uses or if required by law, if we determine there is a possibility that an individual can be identified through implicit deduction based on small cell sizes (instances where the patient population is so small that, because of the small size, use this information to deduce the identity of the beneficiary). POLICIES AND PRACTICES FOR STORING, RETRIEVING, ACCESSING, RETAINING, AND DISPOSING OF RECORDS IN THE SYSTEM: STORAGE: All records are stored electronically. RETRIEVABILITY: All Medicare records are accessible by HICN, SSN, and unique provider identification number. SAFEGUARDS: CMS has safeguards in place for authorized users and monitors such users to ensure against unauthorized use. Personnel having access to the system have been trained in the Privacy Act and information security requirements. Employees who maintain records in this system are instructed not to release data until the intended recipient agrees to implement appropriate management, operational and technical safeguards sufficient to protect the confidentiality, integrity and availability of the information and information systems and to prevent unauthorized access. This system will conform to all applicable Federal laws and regulations and Federal, HHS, and CMS policies and standards as they relate to information security and data privacy. These laws and regulations may apply but are not limited to: The Privacy Act of 1974; the Federal Information Security Management Act of 2002; the Computer Fraud and Abuse Act of 1986; the Health Insurance Portability and Accountability Act of 1996; the E-Government Act of 2002, the Clinger-Cohen Act of 1996; the Medicare Modernization Act of 2003, and the corresponding implementing regulations. OMB Circular A-130, Management of Federal Resources, Appendix III, Security of Federal Automated Information Resources also applies. Federal, HHS, and CMS policies and standards include but are not limited to: All pertinent National Institute of Standards and Technology publications; the HHS Information Systems Program Handbook and the CMS Information Security Handbook. RETENTION AND DISPOSAL: Records are maintained for a period of 6 years and 3 months. All claims-related records are encompassed by the document preservation order and will be retained until notification is received from DOJ. SYSTEM MANAGER AND ADDRESSES: Director, Division of Business Analysis & Analysis, Enterprise Databases Group, Office of Information Services, CMS, Room N1-14-08, 7500 Security Boulevard, Baltimore, Maryland 21244-1850. NOTIFICATION PROCEDURE: For purpose of access, the subject individual should write to the system manager who will require the system name, HICN, address, date of birth, and gender, and for verification purposes, the subject individual's name (woman's maiden name, if applicable), and SSN. Furnishing the SSN is voluntary, but it may make searching for a record easier and prevent delay. RECORD ACCESS PROCEDURE: For purpose of access, use the same procedures outlined in Notification Procedures above. Requestors should also specify the record contents being sought. (These procedures are in accordance with department regulation 45 CFR 5b.5(a)(2)). CONTESTING RECORDS PROCEDURES: The subject individual should contact the system manager named above, and reasonably identify the records and specify the information to be contested. State the corrective action sought and the reasons for the correction with supporting justification. (These Procedures are in accordance with Department regulation 45 CFR 5b.7). RECORDS SOURCE CATEGORIES: The data collected and maintained in this system are retrieved from the following databases: Medicare Drug Data Processing System, System No. 09-70-0553 (70 Federal Register

(FR)58436 (October 6, 2005)); Medicare Beneficiary Database, System No. 09-70-0536 (71 FR 11425 (March 7, 2006)); Medicare Advantage Prescription Drug System, System No. 09-70-4001 (70 FR 60530 (October 18, 2005)); Medicaid Statistical Information System, System No. 09-70-0541 (71 FR 65527 (November 8, 2006)); Retiree Drug Subsidy Program, System No. 09-70-0550 (70 FR 41035 (July 15, 2005)); Common Working File, System No. 09-70-0526 (71 FR 64955 (November 6, 2006)); National Claims History, System No. 09-70-0005 (67 FR 57015 (September 6, 2002)); Enrollment Database, System No. 09-70-0502 (67 FR 3203 (January 23, 2002)); Multi-Carrier Claims System (formerly known as the Carrier Medicare Claims Record), System No. 09-70-0501 (71 FR 64968 (November 6, 2006)); Fiscal Intermediary Shared System (formerly known as the Intermediary Medicare Claims Record), System No. 09-70-0503 (71 FR 64961 (November 6, 2006)); Unique Physician/Provider Identification Number, System No. 09-70-0525, (69 FR 75316 (December 16, 2004)); Medicare Supplier Identification File, System No. 09-70-0530 (71 FR 65527 (November 8, 2006). Information will also be provided from the application submitted by the individual through state Medicaid agencies, the Social Security Administration and through other entities assisting beneficiaries. SYSTEMS EXEMPTED FROM CERTAIN PROVISIONS OF THE ACT: None. [FR Doc. E6-21123 Filed 12-12-06; 8:45 am] BILLING CODE 4120-03-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Proposed Information Collection Activity: Comment Request Proposed Projects *Title:* Evaluation of the Mentoring Children of Prisoners

(MCP)Program. *OMB No.* New Collection. *Description:* The Promoting Safe and Stable Families Amendments, as reauthorized (2006), amended Title IV-B of the Social Security Act (42 U.S.C. 629-629e) providing funding for nonprofit agencies that recruit, screen, train, and support mentors for children with an incarcerated parent or parents. The Family and Youth Services Bureau

(FYSB)of the Administration for Children and Families, United States Department of Health and Human Services, administers the Mentoring Children of Prisoners

(MCP)program. The MCP program provides children of prisoners with caring adult mentors, supporting one-to-one mentoring relationships. Research in other populations has shown that such relationships can lead to reductions in risk behaviors and improvements in academic, behavioral and psychological outcomes in children and youth. Although the MCP program was developed based on research documenting the efficacy of mentoring as a general intervention strategy, it is not yet known whether or not this particular intervention yields positive outcomes for the children of prisoners population. Little is known about how mentoring relationships work for these youth, and how effective mentoring relationships for children of prisoners differ from effective mentoring relationships for other youth. In addition, little is known about children of prisoners in general and thus a survey of MCP program youth has the potential to provide important data about this relatively unstudied population. The evaluation and data collection proposed in this notice are to fulfill the statutory requirement under Section 8, subsection h(1) of the Child and Family Services Improvement Act of 2006, as amended, that the Secretary of the Department of Health and Human Services evaluate outcomes of the MCP program and report to Congress on the findings. The proposed data collections will support a study of the MCP program that measures the program's child outcomes and compares these outcomes in similar programs. The data collection also will provide general information about youth in the program. Finally, the study will include an administrative survey of grantees participating in the study. The proposed study will include baseline and follow-up surveys (to be administered approximately 12 months apart) of youth ages 9-16 in the MCP program and will compare changes in key behaviors for program youth against changes in behaviors of similar youth not enrolled in mentoring programs. By comparing changes for youth in the MCP program against changes for youth not in the program, we will be able to determine if MCP youths' behaviors are closer to the norm for their age group at follow-up than at program intake. If MCP youths' behaviors and outcomes are shown to improve relative to other groups, the MCP program has demonstrated the potential for positive impacts. The survey also will include some general informational questions about youth in the study so that HHS, policy makers, and practitioners can have a greater understanding of the life circumstances of these youth and of some of the challenges they may face. The youth surveys will focus on measuring both attitudinal and behavioral changes in areas targeted by the MCP program including attitudes towards and performance in school; relationships with parents, peers and teachers; self-esteem; and engagement in a variety of risk behaviors, including alcohol and drug use and physical violence. They also will include questions about the living situations of youth in the study, their relationships with both incarcerated and non-incarcerated caregivers, and their relationships with other supportive adults in their communities. The administrative survey of grantees will include questions about the programmatic structure of each grantee. It will provide information about variations in program administration, mentor activities, and youth served. *Respondents:* The proposed study sample consists of a cohort of 625 youth ages 9-16 in MCP programs operated at 10 or more different program sites. Survey data will also be collected from approximately 72 grantees. Annual Burden Estimates Instrument Number of respondents Number of responses per respondent Average burden hours per response Total burden hours Student Baseline Survey 625 1 .5 312.5 Student follow-up Survey 500 1 .5 250 Grantee Survey 72 1 1 72 *Estimated Total Annual Burden Hours:* 634.5 In compliance with the requirements of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Administration for Children and Families is soliciting public comment on the specific aspects of the information collection described above. Copies of the proposed collection of information can be obtained and comments may be forwarded by writing to the Administration for Children and Families, Office of Administration, Office of Information Services, 370 L'Enfant Promenade, SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. E-mail address: *infocollection@acf.hhs.gov.* All requests should be identified by the title of the information collection. The Department specifically requests comments on:

(a)Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility;

(b)the accuracy of the agency's estimate of the burden of the proposed collection of information;

(c)the quality, utility, and clarity of the information to be collected; and

(d)ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Consideration will be given to comments and suggestions submitted within 60 days of this publication. Dated: November 8, 2006. Robert Sargis, Reports Clearance Officer. [FR Doc. 06-9666 Filed 12-12-06; 8:45 am]

Connectionstraces to 7

Traces to 7 documents

CFR

U.S. Code

17 references not yet in our index